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List of Abbreviations 
Aβ Amyloid beta peptide 
AFM Atomic force microscopy  
ANF Atrial natriuretic factor (atrial amyloidosis) 
APP Amyloid precursor protein 
ATR-FTIR Attenuated total reflection Fourier transform infrared 
CD Circular dichroism  
CDNN Circular dichroism neural network 
Chol Cholesterol 
CMC Critical micelle concentration 
CPE Carboxypeptidase E 
DOPC 1,2-dioleyl-sn-glycero-3- phosphatidylcholine 
DOPG 1,2-dioleyl-sn-glycero-3-[phospho-rac-(1-glycerol)] 
DPPC 1,2-dipalmitoyl-sn-gylcero-3-phosphatidylcholine 
Far-UV / near-UV Far ultraviolet / near ultraviolet 
FTIR Fourier transform infrared  
hIAPP Human islet amyloid polypeptide 
Htt Huntingtin 
IAPP Islet amyloid polypeptide 
IRRAS Infrared reflection absorption spectroscopy 
LUVs Large unilamellar vesicles  
mM / µM / nM Millimolar (10-3 M) / micromolar (10-6 M) / nanomolar (10-9 M) 
nm / µm Nanometer (10-9 m) / micrometer (10-6) 
PAM Peptidyl amidating mono-oxygenase 
PC Prohormone convertase 
ProIAPP Proislet amyloid polypeptide 
PrP Prion protein 
rIAPP Rat islet amyloid polypeptide 
rpm Revolutions per minute 
s / min / h / d Second / minute / hour / day 
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SDS Sodium dodecyl sulfate 
T2DM Type 2 diabetes mellitus 
ThT Thioflavin T 
TIA1 T-cell intracellular antigen-1 
TTR Transthyretin 
UV-Vis Ultraviolet-visible 
w/w Weight by weight ratio 
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Chapter 1. Introduction 
 
1.1. Type 2 diabetes mellitus 
The cellular proteome changes constantly according to the requirements arising due to 
the potentially changing chemical environment. For example, changes in the blood glucose 
or the free fatty acid levels affect the proteomics of pancreatic β-cells. This cellular 
proteome regulation is controlled by cellular protein homeostasis, which is also known as 
“proteostasis” (1). It is regulated by the proteostasis network, which includes protein 
translation, folding, trafficking, etc. When there are major changes in the composition of 
cellular moieties compared to the normal composition, this proteostasis network goes awry 
and leads to the onset of diseases, like cystic fibrosis, type-2 diabetes mellitus (T2DM), etc. 
(2). T2DM is one of the diseases in which the proteostasis network of pancreatic β-cells 
goes awry, leading to alteration in the regulation of islet amyloid polypeptide (IAPP) and 
the insulin proteostasis network. In turn, this leads to amyloid deposits of these 
polypeptides in the pancreas and causes T2DM, which is known to affect over 100 million 
people worldwide (3). This disease is marked by high blood glucose levels due to insulin 
resistance, or relative insulin deficiency, which arises due to the death of the pancreatic β-
cells. Pancreatic amyloid deposits have been found in over 90% of T2DM cases, mainly as 
extracellular deposits in the proximity of β-cells of pancreas (4, 5). However, the 
mechanism of cell death by amyloid fibrils or by protofibrils / oligomers is not well known. 
Among the peptides secreted by pancreatic β-cells, the relatively higher 
amyloidogenic propensity of IAPP, as suggested by its sequence analysis as well as its 
ability to fibrillate in vitro, makes this peptide a major culprit of T2DM. However, IAPP 
gene polymorphisms are not universally associated with type 2 diabetes mellitus. It has 
been found that transgenic mice expressing the human IAPP gene have an increased IAPP 
concentration, but develop islet amyloid deposits only on a high fat diet (6). All these in 
vivo experiments pointed out a number of possibilities that could be the possible trigger 
factors for the onset and progression of T2DM in human (Figure 1). Additionally, they also 
pointed out that not only IAPP, but also its precursor processing intermediates could be the 
primary culprit in T2DM under certain conditions. Figure 1 represents the possible factors 
that may involve the onset and progression of T2DM in human. 
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Figure 1: Schematic representation of the potential relationship of islet dysfunction, islet amyloid, and β-cell 
destruction in the pathophysiology of T2DM (adopted from Clark, et al. 2004 (7)). 
 
1.2. Proislet amyloid polypeptide (proIAPP) 
Proislet amyloid polypeptide (proIAPP) is a 67 amino acid long polypeptide, and 
represents the precursor of the physiologically active human IAPP or say amylin (8). 
ProIAPP is translated on the rough endoplasmic reticulum as a secretory protein, inside the 
pancreatic β-cells. Subsequently, it is transferred into the lumen of the endoplasmic 
reticulum, where the disulfide bond between Cys13 and Cys18 of proIAPP is formed (9-
11). The processing of proIAPP to IAPP occurs within the secretory granules of pancreatic 
β-cells. It starts with the removal of 11 residues from the N-terminus and 16 residues from 
the C-terminus of proIAPP, by the actions of the enzymes known as prohormone 
convertase, PC2 and PC1/3 or furin. Thereafter, the basic prohormone convertase 
recognition motif (i.e. Lys52-Arg53) is removed by the action of carboxypeptidase E, 
followed by the peptidylglycine α-amidating mono-oxygenase complex (PAM) that 
removes the Gly38 residue and amidates the exposed carboxy-terminus of Tyr37 (9-12). 
Thus, the normal processing of a 67-residue proIAPP to yield a 37-residue IAPP requires, 
apart from disulfide bond formation between Cys13 and Cys18 of proIAPP, the removal of 
11 residues and 16 residues from the N- and C- termini, respectively. In addition, the basic 
recognition motif and Gly37 are removed, followed by amidation of the carboxy end of 
Tyr37 (Figure 2) (12). ProIAPP is co-processed, co-stored, and co-secreted with insulin as 
IAPP (8, 13). Thus, the physiologically active form of proIAPP, i.e., IAPP is secreted into 
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the extracellular matrix in response to various stimuli to maintain the blood glucose level 
(8, 14, 15). IAPP is known to be involved in glucose metabolism, and to act as an insulin 
antagonist (8). However, the exact physiological role of IAPP is still not clear (16). 
ProIAPP does not show any amyloidogenic propensity in bulk solution, despite its primary 
sequence that shares partly the primary sequence of amyloidogenic IAPP and its precursor 
processing intermediates (17). This non-amyloidogenic property of proIAPP in bulk 
solution has been attributed to the presence of relatively more positively charged residues at 
the N-terminus of its sequence (17, 18). Moreover, the overproduction of proIAPP or IAPP 
does not trigger amyloid deposition inside the pancreas, until there are some mutations that 
favor the fibrillation of these peptides (4). Nevertheless, studies on the nude mice with 
transplanted human islet (19), and on the transgenic mice expressing human IAPP (6) have 
indicated that the early stages of islet amyloid formation may take place intracellularly. 
These intracellular aggregates are found to be immunoreactive for partially processed and 
unprocessed proIAPP (20), underlining the possibility that proIAPP and its precursor 
processing intermediates may be important in the early intracellular amyloid formation.  
The full length proIAPP has made it to the list of potential primary culprits in the 
onset of T2DM, since it has been found that in vitro positively charged N-terminal extended 
proIAPP interacts with negatively charged heparin sulfate proteoglycans (HSPG) (21). 
Thus, this electrostatic interaction with negatively charged cellular moieties may modulate 
its amyloidogenic propensity, which in turn may act as a seed for the amyloid deposition in 
vivo (21). Because of these reasons, the amyloidogenic propensity of proIAPP in the 
presence of charged surface or cellular moieties has been under intense scrutiny, recently. 
Various research groups are working to explore the possible factors, which may affect the 
amyloidogenic propensity of proIAPP and its precursor processing intermediates inside the 
cell, especially in the presence of negatively charged surfaces or moieties that are either 
absent or present in very low quantity at non-pathological conditions. Because of these 
reasons, lipid membranes (largest charged surface present inside the cell) have been studied 
extensively (18, 22-24). 
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Figure 2: Proposed pathway for the normal processing of human proIAPP in pancreatic β-cells. 
Abbreviations: PC Prohormone Convertase, CPE Carboxypeptidase E, PAM Peptidyl Amidating Mono-
oxygenase complex (adopted from Jha, et al. 2009 (18)).  
 
1.3. Amyloid fibrils and their conformations 
Amyloid is a term given to the abnormally insoluble fibrous structure formed by 
otherwise soluble monomeric protein molecules. The process of their formation is defined 
as “amyloidogenesis”. This heterogeneous mechanism of amyloidogenesis is accompanied 
by the various intermediate species, termed as “oligomers”, “protofibrils”, and “fibrils”. 
Since either the intermediate species or the fibrils have cytotoxic property (25), their 
formation leads to the onset of diseases, collectively called “amyloidoses”. The amino acid 
composition and the sequence analysis of the amyloid deposits revealed that each 
amyloidosis is associated with a particular protein/peptide (26). However, the 
amyloidogenic propensity of each peptide depends on several factors like polypeptide 
charge, sequence, hydrophobicity, secondary structure, etc. To date, more than 20 
amyloidoses causing proteins/peptides have been identified (see Table 1) (27). However, 
some non-disease related peptides and proteins have been shown to self-assemble into 
amyloid fibrils under denaturing conditions as well (28, 29); it is now considered that fibril 
formation is an inherent property of all proteins/peptides under certain environmental 
conditions (30). 
 
 
1                      10 20 30 37
TPIESHQVEKRKCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTYGKRNAVEVLKREPLNYLPL
PC 1/3
ProIAPP (67)
NH2-
terminal
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terminal
NH2-terminally
extended 
proIAPP
TPIESHQVEKRKCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTYG
PC2 CPE
+++                       +            
KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2
PAM
Mature IAPP
+ ++                    +                                                          ++            ++
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Table 1: Some amyloidoses and their respective precursors and amyloidogenic proteins (adopted from 
Rambaran, et al. 2008 (27)). 
 
Disease Precursor protein Amyloid protein 
Alzheimer's disease Amyloid precursor protein Aβ peptides 
Atrial amyloidosis Atrial natriuretic factor 
(ANF) 
Amyloid ANF 
Spongiform encephalopathies Prion protein (PrPc) PrPsc 
Primary systemic amyloidosis Immunoglobulin light and 
heavy chains 
AL and AH 
Senile systemic amyloidosis Wild-type transthyretin ATTR 
Haemodialysis-related amyloidosis β2-microglobulin Aβ2M 
Hereditary nonneuropathic systemic amyloidosis Lysozyme ALys 
Type 2 diabetes mellitus (T2DM) Pro-IAPP IAPP or “amylin” 
Injection-localized amyloidosis Insulin AIns 
Secondary systemic amyloidosis (Apo) serum amyloid A Serum amyloid A 
Hereditary cerebral amyloid angiopathy Cystatin C ACys 
Finnish hereditary systemic amyloidosis Gelsolin AGel 
Familial amyloid polyneuropathy I Transthyretin variants ATTR 
Familial amyloid polyneuropathy II Apolipoprotein A1 AApoA1 
Ageing pituitary, prolactinomas Prolactin APro 
Familial amyloidosis Fibrinogen αA-chain AFib 
British familial dementia Amyloid Bri Precursor 
Protein 
ABri 
 
Over the last decades, the abnormally stable conformations of amyloid fibrils have 
drawn the attention of chemists from all over the world. Despite the differences in the 
amino acid sequences of these amyloidogenic peptides, all share a common β-sheet 
conformation of their polypeptide backbone (31, 32). On the basis of experimental studies, 
several molecular mechanisms have been proposed till date, in order to explain the 
formation and the stability of amyloid fibrils in vitro, including polar zipper (33, 34) and 
domain swapping models (35, 36). In the polar zipper mechanism, the complementary 
repeating amino acid sequence of hydrogen donors and acceptors along the side chains 
come together into a β-sheet conformation, as shown in Figure 3. In the domain swapping 
mechanism, a domain of a protein breaks its non-covalent bonds with the remainder of the 
molecule and its place is taken by the same domain of a second molecule, and this 
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propagates into a polymeric conformation with cross-β conformation, as shown in Figure 4. 
An assembly, following a domain swapping mechanism is both energetically and 
kinetically favorable in comparison with the equivalent association of monomers due to the 
increased effective concentration of monomers in the dimer. 
 
 
 
Figure 3: Polar zipper model found in carboxy-terminal peptides of Ascaris hemoglobin arranged in an 
antiparallel pleated sheet with compensating charges (adopted from Perutz, et al. 1994 (34)). 
 
 
 
Figure 4: Schematic representation of a possible assembly of cystatin dimers into a continuous β-sheet 
structure, where dimers are connected via an interface between strands 1 and 5 (adopted from Staniforth, et al. 
2001 (35)).  
 
The amyloid fibrils formed from any amyloidogenic peptides via any of these 
mechanisms share the same core conformation that is a β-sheet placed perpendicular to the 
elongation axis and the direction of hydrogen bonds between the sheets run parallel to the 
elongation axis of fibrils. This arrangement has been studied elaborately by X-ray 
scattering, where the lowest-order reflection, i.e., 4.8 Å, suggests that the amyloid core 
contains 24 β-strands in 115.5 Å-long repeating units each along the fibril axis (Figure 5) 
(31). Most of the native β-sheets have a right handed twist, because right-handed twisted 
conformations represent the lowest energy conformation for a β-sheet. It is assumed that the 
amyloid protofilaments also incorporate the lower energy β-sheets conformation, i.e., right-
handed β-sheet; this twist of the β-sheets has a common axis, which runs parallel to the axis 
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of the protofibrils and accounts for the repeating unit of approximately 115 Å (37, 38). This 
helical nature of protofilaments enables the hydrogen bonding between β-strands to be 
extended over the total length of the amyloid fibrils, thereby accounting for their rigidity 
and stability (31, 39). However, mature amyloid fibrils vary in morphology, depending 
upon the assembly or fibrillation conditions (39). 
 
 
 
Figure 5: Model of the generic amyloid core structure. A number of β-sheets (four illustrated here) make up 
the protofilament structure. These sheets run parallel to the axis of the protofilament, with their component β-
strands perpendicular to the fibril axis (adopted from Sunde, et al. 1997 (31)). 
 
Thus, amyloid fibrils are cross-β in nature, and the β-sheet conformation forms the 
core of the fibril structure. The stability of these β-strands appears to be derived from a 
combination of forces like for native proteins, which includes not only hydrogen bonding 
but also the stacking of side chains between the strands that play a very important role in 
their stabilization (40).  
 
1.4. Mechanism of amyloid formation at membrane interfaces 
It has been shown that some natively unfolded polypeptides, e.g. IAPP (22), α-
synuclein (41), and medin (42), undergo amyloid fibril formation through helical 
intermediate conformations. Since these α-helical intermediate conformations play an 
important role in aggregation processes, all the reagents that induce α-helical conformations 
in these unfolded polypeptides, e.g. surfactants (SDS), TFE (2,2,2-trifluoroethanol), HFIP 
(1,1,1,3,3,3-hexafluoroisopropanol), become very important for studying fibrillation 
phenomena. Amongst all these reagents, studies with surfactants might have a direct 
significance in understanding the possible mechanism of membrane induced fibrillation for 
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unfolded polypeptides in vivo. However, most studies described in literature so far were 
carried out in vitro using isolated target molecules in dilute aqueous environments, thereby 
neglecting a key feature of cellular environments, the confined space and presence of lipid 
interfaces. Normally, nascent amyloidogenic proteins are released in vivo into an 
intracellular environment, which is congested by other large biomolecules. This congestion 
process is called “molecular crowding” (43, 44). Molecular crowding can stimulate self-
association of amyloidogenic proteins (45). However, cell interiors do not only have an 
aqueous three dimensional congested environment, but also display dynamic biological 
membranes with two dimensional surfaces of varying charge and physical properties as a 
response to intracellular conditions (46, 47); these membrane surfaces have been shown to 
affect the protein folding and aggregation (46). Moreover, amyloid deposits analyzed from 
different amyloidoses show the presence of the lipids (48, 49). The exact mechanism of 
spatial and temporal incorporation of lipids into amyloid deposits still remains unclear. The 
amyloidogenic monomeric peptides, as well as intermediate species of amyloidogenesis, 
have been shown to manifest an affinity towards the lipid membrane. It is not clear whether 
this incorporation of lipids happens at the beginning of the amyloidogenesis, whereby the 
lipid acts as a catalyzing surface, or at later stages when these intermediate species interact 
with lipids and cause lipid membrane disruption. In order to understand the role of 
membranes in amyloidosis, and of amyloidosis on membrane disruption, a number of 
studies on amyloidogenic peptides have been undertaken in the presence of simple 
membrane-mimicking surfaces (50), monolayer membrane interfaces (22), and bilayer 
membrane interfaces (18, 51). From all these studies, a general mechanistic model has been 
proposed, suggesting that the interactions of many amyloidogenic peptides with the 
membranes is mainly initiated by electrostatic interactions between charged residues 
present at the peptide and oppositely charged membrane moieties. Thus, an increased 
peptide concentration on the membrane surface, because of the electrostatic interaction, 
facilitates the self-assembly of amyloidogenic structures through hydrophobic interaction 
between monomeric peptide conformations, as shown in Figures 6 (bilayer model) and 7 
(monolayer model) (52-54). 
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Figure 6: Schematic model of association and aggregation of amyloidogenic proteins on a bilayer membrane 
surface: peptide monomers bind electrostatically to a negatively charged membrane surface (left). Membrane-
induced conformational changes (middle) in combination with an increased concentration of surface-bound 
protein initiate and accelerate conversion into β-sheet like amyloidogenic structures (right) (adopted from 
Bystrom, et al. 2008 (55)). 
 
 
 
Figure 7: Schematic model of peptide-lipid monolayer interaction, lipid-induced peptide conformational 
transitions, and fibril formation – upon adsorption of the peptide, a subsequent conformational transition, 
which is then followed by the self-assembly of peptide monomers into amyloid fibrils (adopted from Lopes, et 
al. 2007 (22)). 
 
Thus, the protein aggregation in the sub-three-dimensional environment of membrane 
interfaces may be differentiated into three main steps: 
1) Adsorption of monomeric peptide onto the membrane interface, and the 
subsequent transition into a partially folded conformation. 
2) Formation of the nucleus, or of oligomers. 
3) Formation and growth of the fibrillar structure. 
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 The last two steps of protein aggregation in sub-three-dimensional environments are 
association-driven and the first involves conformational changes. Each of these steps is 
influenced by the molecular crowding or by the membrane-solution interface, arising from 
adsorption at the membrane. Thus, the presence of membrane interfaces, or sub-three-
dimensional environments, modulate the fibrillation kinetics of amyloidogenic peptides. 
 
1.5. Tuned amyloidogenesis 
Amyloidogenesis is a nucleation dependent process similar to crystallization. Thus, it 
is also called “one dimensional crystallization” (56). The kinetics of amyloidogenesis often 
comprises of two stages: a lag phase corresponding to the thermodynamically-disfavored 
nucleation stage and an exponential, thermodynamically-favored stage corresponding to the 
elongation of the nucleus into mature fibrils (57) (Figure 8). Some amyloidogenic peptides 
have been found to show a shortened or fully vanished lag phase of amyloidogenesis in the 
presence of an external nucleus (58). For any amyloidogenic peptide, the nucleus formation 
is the rate limiting step of the fibrillation process. 
 
 
 
Figure 8: Kinetics of spontaneous and tuned (seeded) amyloidogenic self-assembly (adopted from Dzwolak, 
et al. 2006 (57)). 
 
As mentioned in the previous sub-chapter (1.3), the side chain packing of the adjacent 
β-strands of amyloid fibrils plays an important role in the stability of the fibrils. An 
interesting question that arises is how do many polypeptides, whose sequences are evolved 
to fold into stable, globular structures, could be equally well accommodated into the same 
generic conformation of amyloid, i.e., a β-sheet-rich motif? This quest can be answered by 
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finding how efficient the nucleus of one amyloidogenic peptide can be for the fibrillation of 
another amyloidogenic peptide sequence. Additionally, this approach, the so-called “cross-
seeding” approach, gives vital information about the possible involvement of one 
amyloidogenic disease in the onset of another amyloidogenic disease, like the possibility of 
the onset of Alzheimer disease to a T2DM patient, or vice versa. Figure 9 represents the 
very recent model of the cross-seeding approach, whereby Htt (huntingtin) fibrils seeded 
the fibrillation of TIA-1 (T-cell intra-cellular antigen-1, TIA-1 contains no poly(Q) tract), 
leading to pathological diversity (59). 
 
 
 
Figure 9: Model of pathological diversity based on a cross-seeding mechanism. An abnormally expanded 
poly(Q) tract forms fibrillar aggregates, which can induce fibrillation of Q/N-rich proteins by acting as a seed 
(cross-seeding). Various kinds of Q/N-rich proteins (designated as different shapes and/or colors) can be 
potentially recruited into the fibrillar aggregates through a cross-seeding reaction. Likewise, cross-seeded 
fibrils of Q/N-rich proteins may further facilitate fibrillation of the other proteins that can not be directly 
seeded by poly(Q) aggregates (cross-cross-seeding). Given that physiological functions of recruited proteins 
are repressed, cross-seeding reactions will describe diverse pathologies observed in the poly(Q) diseases 
(adopted from Furukawa, et al. 2009 (59)). 
 
1.6. Aim of the research 
Cellular membranes constitute the largest charged surface inside the cell. These cell 
membranes generally display a lateral heterogeneity in their lipid composition, in their 
inner and outer leaflet. The recent outburst of information in lipidomics shows a high level 
of spatial and temporal variability of membrane composition (60, 61). In addition, there 
have been more and more examples of biological processes in which the protein function 
depends on the intricate details of the membrane properties, e.g., the distribution of charged 
phospholipids in the membrane. On one hand, lipids may influence protein function by 
altering the physical properties of the lipid matrix. On the other hand, lipids may also affect 
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protein function by directly binding to certain sites on the proteins; thus, the composition of 
lipids is extremely important in studying any membrane associated biological processes. 
One such classical example, where changes in lipid composition of membranes have 
adverse implications, is Diabetes. In the prediabetic stage, an increased level of free fatty 
acids has been observed. This increased level of free fatty acid leads to the remodulation of 
membrane composition by significantly increasing the negatively charged lipid content. 
The anionic lipid content of the membrane has been found to increase beyond the 
physiological limit of 10-30%. Moreover, it has been hypothesized that proIAPP is 
involved in the intracellular amyloid deposits in the presence of negatively charged cellular 
moieties like heparin sulfate proteoglycans (21) (HSPG), non-esterified fatty acids (NEFA) 
(20), etc. 
The aim of this research is to explore the amyloidogenic propensity of proIAPP and 
its conformational properties, in the presence of lipid membranes. Since no studies 
regarding proIAPP-membrane interaction have been reported so far, in the first step simple 
membrane-mimicking systems were studied, followed by model phospholipid membranes. 
The first part of this work is dedicated to establish the effect of a well-studied negatively 
charged membrane-mimicking agent, SDS (sodium dodecyl sulfate), on the amyloidogenic 
propensity and the conformational properties of proIAPP. The methodology used to 
accomplish this goal mainly involved circular dichroism spectrometry (CD), fluorescence 
spectrometry, and atomic force microscopy (AFM). 
The second part of this project is an extension of the surfactant studies, in which the 
interaction between proIAPP and negatively charged phospholipids (POPG) has been 
explored. Here, the effects of negatively charged lipid monolayers on the amyloidogenic 
propensity and conformational properties of proIAPP at a surface pressure of 10 mN/m and 
30 mN/m were studied, respectively. For this study, infrared reflection absorption 
spectroscopy (IRRAS) and AFM were used as main methods of investigation. 
The third part of the project is built upon the information collected from the results of 
simple negatively charged membrane mimicking lipid and lipid monolayer systems on the 
amyloidogenic propensity of proIAPP. It aimed to study the effect of different compositions 
of negatively charged and zwitterionic lipid bilayer membranes on the amyloidogenic 
propensity and the conformational properties of proIAPP by means of ATR-FTIR 
 22 
 
spectrometry, fluorescence spectrometry, and AFM. This is essential in order to reveal the 
possible mechanisms of prediabetic membrane involvement in intracellular proIAPP fibril 
formation. 
The last part of this work includes the cross-seeding approach to explore the 
efficiency of other amyloidogenic peptides secreted by pancreatic β-cells, like IAPP and 
insulin, in seeding the fibrillation of proIAPP, and vice versa. To accomplish the goal of 
this part, fluorescence and ATR-FTIR spectroscopy, as well as AFM have been used. This 
“cross-seeding” approach would provide an in vitro proof of proIAPP involvement in the 
onset and progression of T2DM in human. 
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Chapter 2. Materials and Methods 
 
2.1. Materials 
2.1.1. Chemicals 
1,1,1-trifluoroacetic acid TFA Merck 
1,2-dioleoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine DOPC Avanti Polar Lipids 
1,2-dioleoyl-2-oleoyl-sn-glycero-3-[phosphor-rac-(1-glycerol)] DOPG Avanti Polar Lipids 
1,2-dipalmitoyl-sn-glycerol-3-phosphatidylcholine DPPC Avanti Polar Lipids 
1-palmitoyl-2-oleoyl-sn-glycerol-3-[phosphor-rac-(1-glycerol)] POPG Avanti Polar Lipids 
Acetone JT Baker  
Acetonitrile JT Baker  
Acrylamid/Bisacrylamide (37.5:1, 30 % w/v) Applichem  
Ammonium persulfate  APS Merck  
Bromphenol blue Serva  
Chloroform CHCl3 Merck 
Cholesterol Chol Sigma-Aldrich 
Coomassie Brilliant Blue G250+R250 Serva  
Deuterium oxide, 99.9 atom% D  D2O Sigma-Aldrich 
Deuterium chloride DCl Sigma-Aldrich 
Enterokinase enzyme EK Novagen 
Ethanol JT Baker  
Ethidium bromide EtBr Sigma 
Guanidine hydrochloride GdnHCl Calbiochem 
Hexafluoro-2-propanol HFIP Fluka 
Hydrochloric acid JT Baker  
Insulin from bovine pancreas Insulin Sigma-Aldrich 
Imidazol Gerbu  
Islet amyloid polypeptide IAPP Calbiochem 
Isopropyl-b-D-thiogalactopyranoside  IPTG Applichem  
Muscovite mica Mica Plano GmbH 
Nickel-nitrilotriacetate resin Ni-NTA Sigma 
N,N,N’,N’-tetramethylethylendiamin (TEMED) Roth  
Sodium chloride NaCl Sigma-Aldrich 
Sodium phosphate dibasic NaH2PO4 Sigma-Aldrich 
Sodium phosphate monobasic Na2HPO4 Sigma-Aldrich 
Sodium dodecyl sulfate SDS Sigma-Aldrich 
Thioflavin T ThT Merck 
Yeast extract, Tryptone YT Gibco  
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All chemicals used for proIAPP purification were of HPLC grade. The plasmid 
(pET32_EK/LIC_ProIAPP) for the expression of proIAPP was a generous gift from Prof. 
Dr. Aphrodite Kapurniotu, Technical University of Munich, Germany. All other chemicals 
were used without further purification. For all experiments deionized water (Except IRRAS 
and FTIR measurements) with conductance > 18 MΩ cm was obtained from ELGA 
PURELAB Classica polisher system, ELGA Lab Water, Celle, Germany. 
 
2.1.2. Proislet amyloid polypeptide (proIAPP) 
Proislet amyloid polypeptide (proIAPP), also known as proamylin, is a 67 amino acid 
polypeptide, and is expressed in the β-cells of pancreas. The physiologically active part of 
this protein is very well known as amylin/islet amyloid polypeptide (IAPP), which is going 
to be discussed in the following sub-chapter. ProIAPP has been found to be a part of the 
intracellular amyloid deposits in transgenic mice expressing the gene for human IAPP (20). 
There are plenty of references, where the factors affecting the amyloidogenic propensities 
of hIAPP have been studied. It has been demonstrated that the N-terminal extended 
proIAPP sequence interacts with the negatively charged surface present inside the cell, like 
HSPG. However, there has not been much of exploratory work of the possible factors that 
can induce these intracellular amyloid deposits of proIAPP, and initiate the extracellular 
amyloid deposits by using these intracellular fibrils as nucleus for IAPP/insulin fibril 
formation. Figure 10 depicts the amino acid sequence of proIAPP. 
 
 
 
Figure 10: The primary sequence of proIAPP (adopted from Abedini et al. (62)). 
 
2.1.3. Islet amyloid polypeptide (IAPP), insulin 
Islet amyloid polypeptide (IAPP) is a 37 amino acid long polypeptide, which is also 
known as amylin. It is a hormone secreted by the β-cells of the pancreas in response to the 
various stimuli due to increased blood glucose level. It acts as an antagonist to insulin, 
another hormone secreted by the same pancreatic β-cells to decrease the blood glucose 
level. Both, IAPP and insulin are co-stored and co-secreted into the extracellular matrix. 
1                      10 20 30 37
TPIESHQVEKRKCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTYGKRNAVEVLKREPLNYLPL
+ ++                    +                                                          ++            ++
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They are also expressed as prohormone, and processed by the same enzymes. Figure 11 
depicts the amino acid sequence of IAPP and insulin with disulfide bonds. 
 
A) IAPP  
   
 
B) Insulin  
   
 
Figure 11: Amino acid sequence of (A) IAPP (adopted from Abedini, et al. (62)), and (B) insulin (adopted 
from Nielsen, et al. (63)). 
 
2.2. Methods 
 
2.2.1. Transformation by electroporation 
An amount of 50 µL of the electro-competent cells, E. coli BL21(DE3), was 
incubated with approximately 1 ng of the plasmid DNA, pET32_EK/LIC_ProIAPP (a gift 
from Prof. Dr. Aphrodite Kapurniotu, Technical University of Munich, Germany), in a 
chilled electroporation cuvette (0.2 µm path length). Thereafter, a high voltage pulse was 
applied (25 µF, 200 Ω, 2.5 kV) using an E. coli Pulser from Biorad. The cells were 
immediately transferred into 1 mL of LB (Luria-Bertani broth) medium and incubated for 1 
h at 37 °C. After one hour, the incubated cells were centrifuged and the supernatant was 
discarded, the remaining pellet was resuspended in 100 µL of LB medium and plated on an 
agar plate containing ampicillin as selection marker. 
 
2.2.2. Protein expression 
A single colony of transformed E. coli BL21(DE3) cells was picked from an agar 
plate using a sterile inoculating loop, and inoculated into 100 mL of LB-medium containing 
100 mg/L of ampicillin. This inoculated sample was kept at 200 rpm in a rotatory shaker at 
KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2
+       +            
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37 °C overnight. The pre-culture was then used to inoculate 6 L of 2x YT medium 
containing 100 mg/L of ampicillin. Cells were left to grow until the OD600 nm of the medium 
reached 0.6 at 37 °C, 200 rpm. At this point, the proteomics of growing cells was induced 
by adding IPTG (isopropyl β-D-1-thiogalactopyranoside) to a final concentration of 1 mM, 
and the cells were left to grow for additional 3 h prior to harvest the cells. Before harvesting 
the cells, 30 µL of sample was mixed with 2x SDS sample buffer and boiled at 95 °C for 10 
min, and run on a denaturing sodium dodecyl sulfate poly-acrylamide gel electrophoresis 
(SDS-PAGE) to estimate the protein expression level (Appendix Figure A). Further, the 
medium was distributed into 600 mL aliquots, and the cells were centrifuged at 4000 g for 
15 min at 4 °C by using an AllegraTM X-22R centrifuge (Beckmann coulter, Germany). The 
cells were washed with 25 mM Tris-HCl buffer, pH 8.0, containing 50 mM of NaCl and 
centrifuged at 3000 g for 30 min. Thereafter, the supernatants were discarded, and pellets 
were stored at -80 °C for further purification of the fusion protein containing the primary 
sequence of proIAPP. 
 
2.2.3. Protein purification 
The pellet stored at -80 °C was thawed and dissolved in 25 mM Tris-HCl buffer (pH 
8.0) containing 50 mM NaCl up to a final volume of 15 mL. Cells were broken by three 
cycles in a microfluidizer (Microfluidics Corporation, Newton, MA). The degree of cell 
lysis was checked by a microscope. The cell lysate was immediately diluted with 8 M 
GdnHCl in 10 mM Tris-HCl (pH 8.0), 100 mM NaCl, to a final concentration of 6 M 
GdnHCl. Here, the role of GdnHCl was to avoid the aggregation of the fusion protein 
containing the primary sequence for proIAPP. The resultant clear solution was centrifuged 
at 48000 g for 30 min at 7 °C using an ultracentrifuge Optima L-70K (Beckman Coulter), 
and the supernatant was stored for further purification steps. The supernatant was loaded on 
a 15 mL Ni-NTA (Nickel-nitrilotriacetate) resin, which was equilibrated with a gradual 
increasing concentration of GdnHCl from 0 to 6 M in 10 mM Tris-HCl buffer (pH 8.0), 100 
mM NaCl. The His-tag of the fusion protein containing the primary sequence of proIAPP 
forms the co-ordinate bond with the Ni2+ present in the resin, and the rest of the unbound 
proteins was washed away with a decreasing gradient of GdnHCl from 6 to 0 M in 10 mM 
Tris-HCl buffer (pH 8.0), 100 mM NaCl. After washing with 10 mM Tris-HCl buffer (pH 
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8.0), 100 mM NaCl (without GdnHCl), the bound fusion protein was eluted with 100 mM 
imidazole in 10 mM Tris-HCl (pH 8.0) containing 100 mM NaCl. The eluate was dialysed 
against 50 mM Tris-HCl, pH 8.0, 50 mM NaCl, and the resulting precipitate was 
immediately dissolved to a final concentration of 4 M GdnHCl, 10 mM Tris-HCl, pH 8.0, 
and 100 mM NaCl. The resulting protein solution was loaded on a C18 column (ProntoSIL 
HPLC, Germany) for further purification by reverse-phase high performance liquid 
chromatography (RP-HPLC) on a Waters 600 chromatography instrument equipped with a 
Waters 2487, dual λ absorbance detector (Waters, Milford, MA, USA). The eluate during 
sample loading, washing, and elution was checked for the fusion protein, having a weight 
of 24.4 kDa, by SDS-PAGE, as well as by liquid chromatography-electron spray ionization-
mass spectrometry (LC-ESI-MS). The elution gradient used was: 10 min at 10% buffer B 
(90% acetonitrile, 0.05% TFA in H2O) in 90% buffer A (0.06% TFA in H2O; 60 min from 
10% to 90% buffer B in buffer A). The flow rate was 2 mL/min, which was maintained 
throughout the run, and the detection of the fusion peptide was performed at 214 nm. The 
fusion protein fraction was confirmed by ESI-MS (Appendix Figure B), then lyophilized 
and dissolved in an enterokinase cleavage buffer (20 mM Tris-HCl, pH 7.5, 50 mM NaCl, 2 
mM CaCl2). The cleavage reaction was performed for 16 h at room temperature (20 °C) 
with an enterokinase (EK) enzyme. The cleavage product was lyophilized, then dissolved in 
10% acetic acid and purified on RP-HPLC with the same elution profile as for the fusion 
protein. The purity and identity of human proIAPP, having a weight of 7514 Da, was 
determined with SDS-PAGE (Appendix Figure A) and ESI-MS (Appendix Figure C) (LCQ 
Advantage MAX, Thermo). The protein concentration was estimated from the absorbance 
at 280 nm in water, using an extinction coefficient of 3230 M-1 cm-1 (64). Following the 
concentration determination, the proIAPP fraction was dissolved in 100 % TFA and then 
distributed to aliquots and lyophilised. It was stored at -20 °C for further use. 
 
2.2.4. Sodium dodecyl sulfate – polyacrylamide gel electrophoresis (SDS-PAGE) 
Preparation of SDS-PAGE 
The resolving gel was prepared by mixing the individual components as indicated in 
Table 2 (shown below), APS and TEMED were added to start the polymerization. 
Thereafter, the solution was poured into a Biorad Multi-casting apparatus, and 50% 
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isopropanol on the top of the resolving gel and the resolving gel solution left to polymerize 
at room temperature. After polymerization of the resolving gel (ca. 30 min), the 
isopropanol was removed from top, and the stacking gel solution was added on top of the 
resolving gel. Further the comb was inserted immediately, and again left to polymerize at 
room temperature (ca. 30min). 
 
Table 2: Recipe for preparing the SDS-PAGE gels. 
 
Adding 
sequence 
1 2 3 4 5 6 
Type of gel 
(%) 
acrylamide/ 
bisacrylamide 
(29:1, 30%) 
Mili-Q 
H2O 
Resolving 
gel buffer 
(4x) 
Stacking 
gel buffer 
(4x) 
10% 
APS* 
TEMED* 
Resolving gel (60 mL) 
10% 20 mL 25 mL 15 mL - 300 µL 30 µL 
15% 30 mL 15 mL 15 mL - 300 µL 30 µL 
Stacking gel (30 mL) 
5% 5 mL 17.5 mL - 7.5 mL 240 µL 30 µL 
 
*TEMED: N,N,N’,N’-tetramethylethylendiamine. *APS: ammoniumpersulfate. 
Resolving gel buffer: 1.5 M Tris-HCl, pH 8.8; 0.4% (w/v) SDS. Stacking gel buffer: 0.5 M Tris-HCl, pH 
6.8; 0.4% (w/v) SDS. Running buffer (10x): 0.25 M Tris-HCl (pH 8.0); 2 M Glycine; 1% SDS. 
 
Gel electrophoresis 
The protein samples were prepared by adding an equal volume of SDS-PAGE sample 
buffer (2x) (62.3 mM Tri-HCl, pH 6.8; 2% w/v SDS; 10% v/v glycerol; 5% v/v β-
mercaptoethanol; 0.001% w/v Bromophenol blue). After heat treatment (60 °C for 5 min), 
the mixtures were loaded on SDS-PAGE, and run at 80 V direct current (DC) until the 
bromophenol blue front entered the buffer solution. SDS-PAGE was stained with 
coomassie staining solution (10% v/v acetic acid; 40% v/v ethanol; 0.1% w/v Comassie 
Brilliant Blue R250) by heating for 2-3 min in a microwave, followed by 1 h on a shaker at 
room temperature. The stained gel was de-stained by keeping it overnight in destaining 
solution (10% v/v acetic acid) at room temperature. 
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2.2.5. LC-ESI-mass spectrometry 
Liquid chromatography-electrospray ionization-mass spectropmetry (LC-ESI-MS) 
analysis was performed on an Agilent 1100 series chromatography system (Hewlett 
Packard) equipped with an LCQ ESI mass spectrometer (Finnigan, San Jose, USA) using 
Vydac 214TP C4 columns (5 µm, 15 x 0.46 cm, 300 Å pore-size) from Phenomeney 
(Aschaffenburg, Germany). For LC separation, a gradient of buffer B (0.1% formic acid 
(FA) in acetonitrile (ACN)) in buffer A (0.1% formic acid in water) with a constant flow 
rate of 1 mL/min was applied, with a gradient program as shown in Table 3. Under these 
conditions, the fusion protein was eluted at 14 min. Mass spectra evaluation and 
deconvolution was performed using the Xcalibur software package and Mag Tran software 
(65). The accuracy of the method for proteins within 25 kDa is approximately ±1-2 Da. 
 
Table 3: The gradient program for LC-ESI-MS measurements of proteins using a C4 column. 
 
Time (min) buffer A (0.1% FA, H2O) % buffer B (0.1% FA, ACN) % 
5 20 80 
15 70 30 
17 90 10 
19 90 10 
20 20 80 
22 20 80 
 
2.2.6 Preparative reverse-phase (RP) – HPLC 
Preparative reversed-phase (RP) chromatography was performed on a Waters 600 
chromatography instrument equipped with a Waters 2487 absorbance detector. ProntoSIL 
C18 column (5 µm, 25 x 0.8 cm, 200 Å pore-size) from ProntoSIL HPLC Germany, was 
used for RP-HPLC. For RP-HPLC the gradient of buffer B (0.1% TFA in Acetonitrile) in 
buffer A (0.1% TFA in water) at a flow rate of 2 mL/min was applied using a gradient 
program described in Table 4. Under these conditions, the fusion protein was eluted at ca. 
38 min, while proIAPP was eluted at ca. 34 min. 
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Table 4: The gradient program used for RP-HPLC measurements using a C18 column, while the flow rate (2 
mL/min) was kept constant throughout the gradient. 
 
Time (min) buffer A (0.1% TFA, H2O) % buffer B (0.1% TFA, ACN) % 
10 30 70 
15 90 10 
10 90 10 
60 10 90 
70 30 70 
 
2.2.7. UV-Vis Spectrometry 
The ProIAPP concentration was measured by following the absorption at λ280 nm on 
PerkinElmer lambda25 model spectrometer (PerkinElmer, USA), and then employing the 
Beer-Lambert’s law. According to the Beer-Lambert’s law, the transmission (T) of light 
through a substance is the product of the molar absorption coefficient of the substance, ε, 
the concentration c, and the distance the light travels through the substance, l, i.e., 
T=I/Io=10-εlc. The absorption coefficient (A) of the substance is given by A = εlc. 
The molar absorption coefficient, ε, for proIAPP was calculated from its amino acid 
sequence (64), which was found to be 3230 M-1 cm-1 at 280 nm. The path length, l, of light 
that passed through the protein sample was 3 mm. 
 
2.2.8. Fluorescence Spectrometry 
Luminescence is the emission of light from any substance, and occurs during the 
transition from an electronically excited state to the ground state. Depending on the nature 
of the transition, it is divided into fluorescence and phosphorescence. The electrons of a 
fluorophore excite by absorption of energy, and attain a higher energy orbital. The electron 
in the excited orbital remains unpaired, and of opposite spin compared to the electron in 
ground state orbital. Consequently, the high energy orbital unpaired electron returns to the 
ground state orbital as a result of spin pairing of electron (“spin allowed”), and this 
transition occurs very rapidly by emission of a photon corresponding to a lower energy than 
the absorbed photons. This property of a fluorophore is called fluorescence. The emission 
rates of fluorescence are typically 108 s-1, so that a typical fluorescence lifetime is near 10 
ns; the life time (τ) of a fluorophore is the average time between its excitation and return to 
the ground state. On the other hand, phosphorescence is the emission of light from triplet 
 31 
 
excited states, in which the electron in the excited orbital has the same spin orientation as 
the ground-state electron. The emission rates are slow, typically 103 - 100 s-1, so that 
phosphorescence lifetimes are typically in the range of milliseconds to seconds. Sensitivity 
at the scale of nanoseconds has made fluorescence a powerful technique for studying bio-
molecular interactions. The technique has become quite popular also because of its 
exquisite sensitivity to the immediate environment of the probe, and due to the generally 
high signal to noise ratio (66). 
 
 
 
Figure 12: Jablonski diagram (67). Symbols from the diagram: S1, S2, and S0 stand for the singlet states of the 
excited states 1, 2, and of the ground state, respectively. IC stands for internal conversion. ISC stands for 
intersystem crossing, while T1 stands for triplet state; hνA, hνF, hνP stands for the energy of absorbance, 
fluorescence, and phosphorescence, respectively. 
 
2.2.8.1. Thioflavin T: a fluorescent dye and its applications 
Thioflavin T (ThT) is a cationic benzothiazole dye that has a special affinity towards 
amyloid fibrils (68). On binding to amyloid fibrils, the fluorescence characteristic of this 
benzothiazole dye changes. Unbound ThT has its excitation maximum at 385 nm, and the 
emission is at 445 nm. Upon interaction with fibrillar or prefibrillar structures, the 
excitation maximum shifts to 450 nm and the emission maximum to 482 nm, respectively 
(69-71). Due to the specificity of ThT binding to amyloid fibrils, it has found many 
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applications such as diagnosis of amyloid fibril formation in vivo by using fluorescence 
microscopy (68, 72), monitoring extracted amyloid fibrils and in vitro amyloid fibrils 
formation using fluorescence spectrophotometry (69, 70), and direct observation of amyloid 
fibril growth using total internal reflection fluorescence microscopy (73, 74). The chemical 
structure of ThT (Figure 13) has a hydrophobic and a relatively polar end. 
 
 
 
Figure 13: Chemical structure of thioflavin T (70). 
 
The polar end of ThT is a polar benzothiazole group consisting of polar atoms such as 
N and S. It has been suggested that the polar nitrogen of thiazole dye forms hydrogen bonds 
with the hydroxyl groups of tissue structures and causes the above mentioned transitional 
shifts in fluorescence characteristics of the dye (75). However, there is not much known 
about the binding mechanism of ThT to amyloid fibrils. 
For this project, ThT has been employed to follow the fibrillation kinetics of proIAPP 
in the absence and presence of SDS, LUVs, lipid rafts and seeds from different 
amyloidogenic peptides/proteins by fluorescence spectroscopy. For the SDS experiments, 
10 µM ThT was used, while the fibrillation kinetics in the presence of LUVs, lipid rafts and 
seed reactions were followed with 50 µM of ThT in the reaction mixture. 
The fluorescence emission intensity of ThT was measured using a K2 multifrequency 
phase and modulation fluorometer with photon counting mode equipment (ISS Inc., 
Champaign Ill, USA). Figure 14 represents the typical set up of a K2 fluorescence 
spectrophotometer. 
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Figure 14: A schematic representation of the K2 fluorescence spectrophotometer (courtesy of ISS, Inc.). 
 
The instrument has a xenon arc lamp as the source of excitation light, having a 
spectrum between 190 and 1100 nm. This xenon lamp emits a continuous light beam, as a 
result of recombination of electrons with ionized xenon (Xe) atoms. These charged Xe 
atoms are generated by the collisions of atoms with the electrons flowing across the arc. 
This continuously emitted light is focused with the help of lenses on the entrance slit of the 
excitation monochromator. A monochromator accepts the incoming light and disperses it 
into the various colors of the spectrum. This dispersion can be accomplished using prisms 
or diffraction gratings. In the K2 spectrophotometer, the spectral dispersion is achieved by 
means of holographic gratings with 1200 grooves per millimeter. The spectral region is in 
the range of λ = 200 – 800 nm with allowance of ∆λ = 0.25 nm. Both monochromators are 
equipped with a set of interchangeable slits of 2, 1, 0.5 mm, respectively. Since the linear 
dispersion of the monochromator is 8 nm/mm, slits have a bandwidth of 16 nm, 8 nm and 4 
nm. The monochromatic light is stirred afterwards over a mirror which is fastened to the 
corner of a two-way polarizer, directly on a beam splitter. A beam splitter is provided in the 
excitation light path, which reflects part of the excitation light to a reference cell, in this 
rhodamine-B, a stable reference fluorophore. The excitation spectra are distorted primarily 
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by the wavelength dependence of the intensity of the exciting light. This intensity can be 
converted to a signal proportional to the number of incident photons by the use of a 
“quantum counter”. This concentrated solution absorbs virtually all incident light in the 
range of 200 - 600 nm. The quantum yield and emission maximum (~ 630 nm) are 
essentially independent of the excitation wavelength from 220 – 600 nm. Rhodamine-B 
remains the most reliable and convenient “quantum counter”. 
Polarizers are present in the both excitation and emission light paths. Generally, the 
polarizers are removable so that they can be inserted only for the measurement of 
fluorescence anisotropy or when it is necessary to select a particular polarized component 
of the emission and/or excitation. In the sample space, there are two possibilities for 
inserting cells, either the cuvette holder with thermostat or the high-pressure autoclave. In 
the right emission channel, light emitted by the sample is spectrally divided by the emission 
monochromator. Like the excitation monochromator, the emission monochromator also 
contains concave holographic gratings with 1200 grooves per millimeter as a dispersive 
element. The emission monochromator grating is maximized for fluorescence light 
detection in the region 350 - 800 nm. Additionally, the slits for optical filters are indicated 
in both, left and right, emission paths directly behind the polarizer and the monochromator, 
respectively. Optical filters are used to compensate for the slight fluctuation from ideal 
behaviour of the monochromators. The detection of the emission light is facilitated by two 
photomultipliers, on the left and on the right side of the sample area. The emitted 
fluorescence radiation is focused first by a lens. The focused emission radiation passes 
through a monochromator and filters to the detector. Most of the fluorometers use 
photomultiplier tubes (PMTs) as detectors. These PMTs are regarded as extremely sensitive 
detectors of light in the ultraviolet, visible, and near-infrared ranges. Since these detectors 
multiply the current produced by received light by million times, enabling individual 
photons of received light to be detected when the incident flux of light is very low. 
Although a PMT responds to individual photons, these individual pulses are generally 
detected as an average signal. 
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2.2.9. Circular dichroism spectrometry 
An electromagnetic radiation is composed of two mutually perpendicular field 
vectors, an electric and magnetic field vector. These field vectors align at 90° to the axis of 
propagation of the electromagnetic radiation. By convention, the polarization of light is 
described by specifying the direction of the radiation’s electric field vector, as shown in 
Figure 15.  
 
 
Figure 15: Schematic diagram of linear, circular, and elliptical polarized light propagation. 
 
When electric field vectors are aligned in one direction, the radiation is called linearly 
polarized radiation or plane polarized light. While, when the electric field vector keeps 
rotating as the wave propagates, the radiation is called circular or elliptical polarized light. 
In the latter case, the amplitude of rotating electric field vector determines the nature of 
polarization. If the amplitude is the same, it is called circularly polarized light, if not then it 
depends upon the magnitude of the amplitude of the two perpendicular component vectors 
of the rotating electric field. It can be rightward or leftward, which in turn depends upon the 
molar absorption coefficient of a compound towards the circular polarized light. Only 
certain compounds have such characteristics, i.e. different molar absorption coefficient for 
left and right circular polarized light. These compounds are called “chiral” or optically 
active compounds. In a protein, the peptide bonds [-(O)C-N(H)-] are the chiral centers in 
the protein molecule. 
A circular dichroism (CD) spectrometer is used to measure the interaction of 
polarized light with the optically active compounds (asymmetric compounds). Asymmetry 
can result from a chiral center (as mentioned above, a peptide bond of a protein molecule), 
a non-chiral molecule (aromatic amino acid side chains) covalently attached to a chiral 
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molecule, or a non-chiral molecule in an asymmetric environment (a chromophore bound to 
a protein). Proteins are optically active molecules, as the peptide bonds have a chiral center, 
as well as all amino acids contain at least one chiral center, except glycine. The resulting 
CD signals are sensitive to the arrangement and coupling of those peptide bonds in different 
secondary structures (far-UV CD), and packing of side chains in the tertiary structure (near-
UV CD). The secondary structures of proteins interact preferentially with one circular 
polarization, allowing one to follow the changes in protein structure using circular 
dichroism spectrometry. 
By definition, CD is a measure of the differential absorbance between the left and 
right circularly polarized light:  
∆A = ∆εlc, where ∆ε = εl - εr 
 
Therefore, it would be logical to use ∆ε as CD data. However, for historical reasons, 
the CD data are often expressed not as ∆ε but in terms of the molar ellipticity, i.e. θ(λ), 
which has units of deg cm2 dmol-1. When plane polarized light passes through a solution of 
optically active compounds, the left and right circularly polarized components of the plane 
polarized light are absorbed by different magnitudes. When these components are 
recombined, they appear as elliptically polarized light. The ellipticity is the angle θ, the 
tangent of which is the ratio of the minor to major axis of the ellipse. 
CD spectra of proteins and peptides are usually measured in two spectral regions. In 
the far-UV region (180 - 260 nm), the measured bands represent the electronic transitions 
of the amide bonds of the protein backbone. The sign, magnitude, and position of these 
bands are strongly dependent on the arrangements of the peptide bonds in different 
secondary structures. Thus, the CD spectra in the far-UV region provide information about 
the content of secondary structures or changes in the secondary structure content of a 
protein in solution. Moreover, the near-UV region (250 - 350 nm) accounts for the packing 
of side chains of aromatic amino acids and disulfide bonds. Thus, the near-UV CD signal 
depends upon the local environment of the aromatic amino acid side chains and their 
packing/orientation with respect to the backbone of the protein. 
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2.2.9.1. Far-UV CD spectra and protein secondary structure 
The most stable and abundant elements of regular, secondary structures are α-helices, 
parallel and antiparallel β-sheets (38). All proteins can be grouped into five classes 
according to their secondary structures: 
1) All α proteins, which show a strong double minimum in the CD spectra at 222 nm, 
208 ±2 nm, and a strong maximum at 191 ±2 nm. 
2) All β proteins have a single negative minimum at 216 ±3 nm and a single positive 
maximum between 190 nm and 200 nm. In contrast, a highly distorted β-sheet or 
β-sheets made up of short irregular β-strands show a strong negative band near 
200 nm, similar to unordered forms (76). 
3) Proteins with both, α and β, conformation but in separate domains. 
4) Proteins with intermixed strands of α/β conformations along the polypeptide 
chain. 
5) Unordered or denatured proteins have little ordered conformations; they show a 
strong negative band near 200 nm and some week bands between 220 nm and 230 
nm, which can have either positive or negative signs. 
 
For α+β and α/β proteins, the ellipticity of α-helices predominate that of β-sheets. 
However, in a few cases a single broad minimum CD band may appear between 210 nm 
and 220 nm because of the overlapping ellipticity signal of various α-helices and β-sheets. 
For α+β proteins, the 208 (±2) nm band ellipticity is higher than the 222 nm band, and the 
reverse is true for the α/β proteins (77). 
The estimation of the secondary structure of a protein from its CD spectrum remains 
an empirical task, despite of many programs proposed to analyze the data. This is because 
of the lack of a unique solution for the deconvolution of a CD spectrum. Most of the 
deconvolution methods assume that the spectra are a linear combination of reference 
spectra for the five secondary structures (helical conformation, parallel and antiparallel β-
sheet, β-turn and random coil). A relatively new program, circular dichroism neural 
network (CDNN) has been recently established as an alternative to the statistical methods 
(78). 
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Figure 16: Schematic topology of a NN (neural network). Data are presented to the input layer; for each data 
point (at each wavelength) there is a separate processing element (neuron), which processes the data and send 
the result via weighted connections to each neuron in the next layer (hidden layer). The adaptation of weights 
is performed in the learning phase. The output consists of five neurons that represents the five fractional states 
(78). 
 
This program uses a back-propagation network model (79) with a single hidden layer 
between input and output (Figure 16), to deduce the five different secondary structures with 
satisfactory correlations between calculated and measured secondary structure data. As 
shown in Figure 16, in this program neuron of a given layer is connected to all neurons in 
the next layer through randomly weighted (numerical weight) connections. Information is 
passed though these connections and processed in the neurons by adjusting the numerical 
weights iteratively, through back-propagation method (79), until all patterns presented to 
the input layer are correctly projected on the output layer in the training phase of program. 
These adjustments of numerical weights come from the difference in the actual output and 
the calculated output, i.e., residual error. Thus, the back-propagation algorithm of the 
network is repeated until the residual error in the output layer reaches a minimum. This 
neural network program represents the relatively most elegant method of non-algorithmic 
deconvolution of experimental CD spectra. Moreover, direct comparison of different 
methods is not possible because of the different reference spectra and algorithms that are 
used by different methods.  
 
2.2.9.2. Sample preparation and instrument set-up - CD 
Aliquots of proIAPP were dissolved in the respective reaction buffer, and the CD 
spectra were measured with a J-715 model from JASCP (Easton, MD) under constant 
nitrogen flush. The parameters used for the CD measurements are given in Table 5. 
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Table 5: Parameter used for all CD measurements. 
 
CD parameters 
Sensitivity Standard (100 mdeg) 
Start wavelength 260 nm 
End wavelength 190 nm 
Data pitch 1 nm 
Scanning mode Continuous 
Scanning speed 50 nm/min 
Response 2 sec 
Band width 1.0 nm 
Accumulation 5 
 
Each CD spectrum is an average of 5 scans. An external water thermostat was used to 
control the temperature within ±0.1 °C. After each measurement, the CD spectra were 
normalized, baseline corrected, and translated into mean residue ellipticity (MRE) by using 
the spectra analysis software from Jasco. The secondary structure content of the peptide 
was determined using a CD spectrum deconvolution program, CDNN (78), using 66 input 
neurons for wavelengths from 190 to 260 nm, five output neurons for the secondary 
structure elements, and one hidden layer with 45 neurons (78). 
 
2.2.10. Infrared spectrometry 
One of the best ways to recognize any compound, or changes in its conformation is 
through the functional groups present in the compound. Currently, several methodologies 
have been established to understand kinetic processes by following the functional groups, 
like Infrared spectrometry (FTIR, IRRAS). The bonds in a molecule are dynamic in nature. 
The nature of this dynamicity includes symmetric, asymmetric stretches, and bending 
vibrations either in-plane or out-of-plane. The frequency of these motions falls in the 
infrared region of the electromagnetic spectrum. When these bonds are exposed to infrared 
radiation, energy is absorbed by the particular bonds, corresponding to their respective 
resonance frequency. This change is observed by infrared spectrometers (IRRAS, FTIR). 
For example, a C-H bond displays stretching vibrations around 3000 - 2840 cm-1. 
Depending upon its vicinity from the neighboring group, the frequency of the bond 
vibration varies. Similarly, the C=O, N-H groups of the peptide bond have their unique 
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vibration bands in the IR spectrum. Opaque samples are difficult to analyze in the usual 
absorbance mode. Other techniques such as attenuated total reflection Fourier transform 
infrared spectroscopy (ATR-FTIR), or infrared reflection absorption spectroscopy (IRRAS) 
proved to be very useful in this case. 
 
2.2.10.1. Infrared reflection absorption spectroscopy (IRRAS) 
IRRAS can be used to monitor a wide range of functional groups present on the 
surfaces (like lipid membranes), in addition to their orientation on the surfaces. This 
technique is typically applied to thin films on highly reflective surfaces, therefore often 
applied to self assemble monolayers (SAMs) on the solid surfaces like Teflon, gold, etc. 
Since infrared radiation is incident at grazing angle in IRRAS, it is also known as grazing-
angle infrared spectroscopy (GARIS). At this incident angle, the electric vectors of p-
polarized light interacts constructively and gives a better intensity signal for IRRAS 
spectra. On the other hand, the electric vector of s-polarized infrared radiation is negligible 
at all angles, since it undergoes a 180° phase shift relative to each other (parallel and 
perpendicular components), therefore cancels through the destructive interface, resulting in 
negligible absorbance. Thus, the only active vibrations observed, consist of bonds vibrating 
in the direction normal to the solid surface. These properties of IRRAS make it a valuable 
method to study lipid-protein interactions by analysis of the amide-I and –II bands, and is 
the only method capable of monitoring directly the protein’s secondary structure, in situ, 
and its orientation associated with lipid films, also in a time-dependent fashion and as a 
function of the lipid monolayer pressure (22). Although IRRAS spectra provide information 
in terms of frequencies and intensities, molecular structures and interactions are interpreted 
from the frequency, while the protein structure and interaction details are studied by 
following the frequency of the amide-I band, mostly due to the C=O stretching of the 
peptide bond. Moreover, quantitative analysis of the intensity data provides information 
about the molecular structure’s orientation. Some of the studies with IRRAS have provided 
data on acyl chain orientation as a mean tilt from the surface normal in ordered 
phospholipid (22), and fatty acid monolayer films (80). 
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2.2.10.2. Instrumentation and experimental part - IRRAS  
IRRAS spectra were recorded with an Equinox 55 FTIR spectrometer (Bruker, 
Karlsruhe, Germany) connected to an XA 511 reflection attachment (Bruker) with an 
external narrow band mercury-cadmium-telluride (MCT) detector using a trough system 
(81). The infrared light was focused onto the D2O-liquid interface and different angles of 
incidence could be adjusted. The trough system was positioned on a movable platform to 
shuttle the focus beam from sample to reference trough without any interference from 
absorption of infrared light by water vapor (82). Two Teflon troughs of different sizes (300 
x 60 x 3 mm3 and 60 x 60 x 3 mm3 for sample and reference trough, respectively) were 
linked by three small water-filled bores to ensure equal height of the air-water interface in 
both troughs. The temperature of the subphase was maintained at 20 ±0.5 °C, and a 
Plexiglass hood covered the trough to minimize the evaporation of water (Figure 17) (81). 
 
 
 
Figure 17: IRRAS apparatus: Top view (left) and with attached plexiglass box (right), employed to follow the 
proIAPP aggregation in the presence of lipid monolayers (courtesy to Dr. A. Kerth, Martin-Luther-University, 
Halle-Wittenberg, Halle / Saale, Germany). 
 
All experiments were performed in the small (reference) trough, the large trough 
filled with buffer solution (10 mM NaH2PO4 and 100 mM NaCl), only. Protein adsorption 
experiments at the air-D2O interface were started by filling the protein-containing buffer 
solution into the small trough just before running the infrared reflection absorption 
measurements. The lipid-protein interactions were studied at constant surface area by filling 
the protein-containing buffer solution into the small trough. Then the uppermost thin layer 
of the air-protein-buffer interface was sucked off just before the lipid monolayers were 
formed by directly spreading the lipid solution (POPG, ~ 1 mM) in a mixture of chloroform 
and methanol (3:1) onto the subphase until the required surface pressure was reached. The 
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lyophilized proIAPP aliquot was dissolved in 10 mM NaH2PO4 buffer, containing 100 mM 
NaCl, to obtain a final concentration of 1 µM (1.67 µM in the case of proIAPPSer13,18) 
before the start of the experiment. 
 
2.2.10.3. Attenuated total reflection Fourier transform infrared spectroscopy (ATR-
FTIR) 
Attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) is 
one of the most powerful methods for recording IR spectra of biological materials in 
general, and for biological membranes in particular. It is fast, yields a strong signal with 
only a few micrograms of sample, and most importantly, it yields information about the 
orientation of various parts of the molecule under study to be evaluated in an oriented 
system. The environment of the molecules can be modulated so that their conformation can 
be studied as a function of temperature, pressure, as well as in the presence of membrane 
surfaces. A unique advantage of IR spectrometry is that it allows a simultaneous study of 
the structure of lipids and proteins in intact biological membranes without introduction of 
foreign perturbing probes. Additionally, because of the long infrared wavelength, light 
scattering problems are virtually nonexistent; thus, highly aggregated materials or large 
membrane fragments can be investigated. 
In an ATR-FTIR spectrometer, there is an internal reflection crystal (for example, Ge, 
Si) that is covered with lipid layer(s) or sample to be studied, containing reconstituted 
protein or amyloid fibrils, and the infrared beam is focused into the crystal (Figure 18). The 
light travels inside the plate by means of a series of internal reflections from one surface of 
the plate to the other, creating an exponentially decaying evanescent radiation outside the 
plate, as shown in Figure 18. Absorption of the evanescent wave energy by the supported 
membrane and the reconstituted protein provides ATR-FTIR spectra. The decay length of 
the evanescent wave (here, ~ 0.6 µm) extends far beyond the dimensions of largest proteins. 
By using polarized light in ATR-FTIR measurements, the orientation of the protein with 
respect to membrane lipids can be obtained. The spectra of protein-lipid systems not only 
comprise of resolved bands of membrane lipids and proteins, they also differentiate 
between different functional groups of these molecules. For studying any processes 
regarding proteins/peptides, generally amide bond vibrations are recorded. Among those 
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bond vibrations, the amide-I band (~ 1700 – 1600 cm-1) is most sensitive to different 
secondary conformations (83, 84). 
 
 
 
Figure 18: Left: schematic representation of a single reflection of infrared radiation and production of an 
evanescent wave. Right: schematic representation of total internal reflection and generation of an evanescent 
wave by internal reflecting elements (IRE). 
 
2.2.10.4. Instrumentation and experimental part – ATR-FTIR 
The ATR-FTIR spectroscopic measurements (85) were performed using a Nicolet 
6700 FTIR-spectrometer equipped with a liquid nitrogen-cooled MCT-A detector. The 
spectrometer chamber was continuously purged with dry air to remove water vapor. The 
ATR out-of-compartment accessory consists of a liquid jacketed Piketech ATR flow-
through cell made of steel. A trapezoidal Ge-Crystal (Piketech, Madison, WI, 80 mm x 10 
mm x 4 mm, angle of incidence: 45°) was used as internal reflection unit (IRE). A 
background spectrum of air was collected using the same IRE before the sample 
measurements. Typically, spectra of 128 scans were taken with a resolution of 2 cm-1. The 
measurements were usually performed at 25 °C. Processing of the ATR-FTIR spectra was 
performed using GRAMS-Ai 8.0 software (Thermo Electron). After subtraction of a 
spectrum of the lipid-membrane together with the buffer and subtraction of noise from 
water vapor, the spectra were baseline corrected between 1710 and 1585 cm-1 and also 
offset corrected. To follow the changes in secondary structure with time, the spectra were 
normalized by setting the area between 1710 and 1585 cm-1 of the amide-I’ (amide-I bond 
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vibration in D2O) band to 1, to compare differences in the adsorption propensities at the 
crystal and membrane surface, respectively. 
For all infrared spectrometric experiments, a phosphate buffer (10 mM PO43-, pD 7.4) 
in D2O, containing 100 mM NaCl, was used. Stock solutions of the lipids were prepared by 
dissolving a mixture of 7 mg DOPC and 3 mg DOPG in chloroform up to a total lipid 
concentration of 10 mg/mL. 50 µL (containing 0.5 mg of lipids) of this solution were dried 
under a stream of nitrogen. When all chloroform was evaporated, the samples were placed 
in a Speed-Vac (SC110, Savant) for 3 h in order to remove residual chloroform. 
 
Large unilamellar vesicles (LUV) and membranes 
Stock solution of 0.5 mg of the lipid mixture (anionic: DOPC/DOPG 7:3, 8:2 or 9:1, 
lipid raft mixture: DOPC:DPPC:Chol 1:2:1, or pure DOPC) were prepared in 
chloroform:methanol (3:1) solution. Solvent was evaporated with the help of nitrogen gas, 
and then dried completely by lyophilisation overnight. The lyophilized lipid mixtures were 
re-dissolved in 1 mL of 10 mM phosphate buffer, pH 7.4, containing 0.1 mM NaCl, and 
ultrasonicated for 10 min. After 5 cycles of freezing and thawing, a homogeneous solution 
of multilamellar vesicles (MLVs) was obtained. To obtain a solution of large unilamellar 
vesicles (LUVs), the MLV solution was passed 11 times through an extruder with a 
membrane filter made of polycarbonate (Avanti, pore diameter: 0.1 µm). In case of the lipid 
raft mixture, the extrusion step was performed above its transition temperature, at 60 °C. 
The freshly prepared solution of LUVs was injected carefully into the ATR-flow-cell, 
which was maintained at 25 °C (Figure 19). In case of the lipid raft mixture, the cell 
temperature was kept at 60 °C. Spreading of the vesicles took place spontaneously. After 
adsorption on the crystal overnight, the membrane was washed with buffer for a time period 
of 6 h (in case of the lipid raft mixture at 30 °C, the cell was kept at 25 °C before the 
peptide solution was added). For this purpose, 2 mL of buffer was pumped from a reservoir 
into the sample compartment (1.4 mL/min). Lipid vesicles, which did not strongly attached 
to the surface of ATR crystal, were washed away by the buffer solution. 
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Figure 19: Schematic representation of the ATR-flow-cell along with the focusing element, IRE (ATR 
prism). 
 
Adsorption and washing of the lipid membrane 
The adsorption of the membrane was followed by monitoring the band intensity of the 
lipid-bands over time. For this purpose, a buffer spectrum was subtracted and spectra were 
baseline corrected in the region of the acyl-chains of the lipids between 3060 and 2820 
cm-1. Then, the area was determined by integration between 3030 and 2810 cm-1. During 
the washing process, spectra were collected likewise performing the same steps. To check 
the membrane preparation and the reproducibility of the membrane deposition procedure, 
the area of the acyl-chain region was determined by integration between 3030 and 2810 cm-
1
 (average area: ∼ 2.25 cm-1). As shown in earlier studies, we may assume that after the 
washing step, one double layer of lipids is left on the IRE, only (85). 
 
 
Adsorption of ProIAPP to the lipid membrane and aggregation 
To ensure the integrity of the membrane, a proIAPP solution of 10 or 40 µM proIAPP 
was injected into the ATR-cell containing membrane by means of a peristaltic pump at 1.4 
mL/min. Then the change of the amide-I’ band was followed over time. Spectra were 
collected every 30 min over a time period of 7 d. 
 
Analysis of the secondary structure changes of proIAPP 
Second-derivative and Fourier self-deconvolution (FSD) were applied to the 
normalized spectra to identify the components in the amide-I’ band region. These peaks 
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were then fitted to the normalized raw spectra according to the least squares condition, 
using a Levenberg-Marquardt curve fitting routine with bands of Voigt line shape. The 
starting width at half height of each peak was 8 cm-1. Each peak position was restricted to 
move not farther than 1 - 3 cm-1 (as determined by the shifts in the second derivative and 
FSD) from their centres during the fitting routine. Such spectral shifts were allowed to take 
into account differences in the dielectric environment and conformational dynamics of the 
secondary structures. All spectra were fitted with a similar set of peaks and parameters. In 
ambiguous cases (such as the well-known overlap of the α-helical and unordered band 
regions), information from CD and NMR experiments were taken into account was well. 
The area under each peak represents the fraction of each component (assuming similar 
transition dipole moments for the different conformers) and was finally used to determine 
the percentage of secondary structure components (86). 
 
Native structure of proIAPP 
For the determination of the secondary structures of the native form of proIAPP, a 10 
µM solution of peptides was injected into the ATR-flow-cell and after a few minutes, an 
ATR-FTIR-spectrum was collected. 
 
Amide-I’ band of fibrils grown by cross-seeding experiments 
To check the secondary structure of the fibrils grown in the presence of seeds, 400 µL 
of the samples were taken and spread on the silicon crystal, and ATR-FTIR spectra were 
collected with time. 
 
2.2.11. Atomic force microscopy (AFM) 
Scanning probe microscope (SPM) is a branch of microscopy that provides 
information about the surface and its properties by scanning the specimen line by line using 
a physical probe (87). Atomic force microscopy (AFM) or scanning force microscopy 
(SFM) is a very high-resolution microscopy technique of the SPM family. A stylus, which 
raster-scan a surface with sufficient proximity or mechanical contact, is used in AFM to 
monitor the changes in the magnitude of the interaction between probe and specimen. 
Thereby, the resolution depends on the sharpness of the tip, the precision with which the 
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probe can be moved over the surface, and the sensitivity with which the interactions are 
detectable. AFM is not only capable of depicting surfaces with atomic resolution (88) or 
even subatomic resolution (89), but also of achieving a sub-molecular resolution in aqueous 
or gaseous medium (90). The working principle of the AFM is based on the deflection of an 
ultra sharp tip (stylus), which is mounted at the free end of a cantilever of 100 - 200 µm 
lengths that reflects a laser beam onto a photodiode. As the tip moves in response of the 
surface topography during scanning, the reflection of the laser beam changes, and the laser 
spot falling onto the photodiode moves in response, producing changes of intensity in each 
of its four segments. The photocurrent’s differential signal between the top and the bottom 
segments contains the topographic information, whereas the orthogonal difference 
quantifies any lateral or twisting motion of the tip (91). By these means, frictional 
information can be distinguished from topographic information. In the simplest operating 
mode, the tip-sample distance is regulated by a feed-back in a way that the cantilever 
deflection (i.e. probed interaction) remains constant during a scan. The resulting control 
signal is recorded as a function of the lateral tip position, and converted into a false colour 
image, wherein the colour graduation reflects the extent of vertical displacement (92). The 
scheme shown in Figure 20 depicts the main part of AFM and working principle as 
described above. 
 
 
 
Figure 20: Scheme of the main components of an atomic force microscope. This device incorporates an 
electronic unit and a computer station equipped with image and command monitors. The microscope itself 
includes a piezoscanner, a probe and a laser beam deflection system (93). 
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Instrumentation and experimental part - AFM 
The surface scans were recorded on a MultiMode scanning probe microscope 
equipped with a Nanoscope IIIa controller from Digital Instruments (Santa Barbara, 
California, USA). The microscope was coupled to an AS-12 E-scanner (∼ 13 µm), and an 
Extender Electronics Module EX-II (Santa Barbara, California, USA), which allows the 
acquisition of phase images. Typically used AFM probes were aluminium coated NCMR 
silicon SPM sensors (force constant ∼ 42 N/m; length ∼ 125 µm; resonance frequency of 
250 ±50 kHz; nominal top radius of curvature ≤ 5 nm) from Nanosensors, Budgetsensors. 
The AFM head with optical block and base was placed atop a commercially available 
active, piezo-actuated vibration damping desk from Halcyonics (Göttingen, Germany). All 
measurements were done in the air using TappingModeTM. 
TappingModeTM AFM operates by scanning a tip attached to the end of an oscillating 
cantilever across the sample surface. The cantilever oscillated at or near its resonance 
frequency with amplitude ranging typically from 20 nm to 100 nm. The probe (stylus) 
lightly “taps” the sample surface during scanning, contacting the surface at the bottom of its 
swing. The feedback loop maintains constant oscillation amplitude by maintaining a 
constant root mean square of the oscillation signal acquired by the split photodiode 
detector. The vertical position of the scanner at each (x, y) data point, in order to maintain a 
constant “setpoint” amplitude, is sorted by the computer to form the topographic image of 
the sample surface. By maintaining the constant oscillation amplitude, a constant tip-sample 
interaction is also preserved during imaging. When imaging in air, the typical amplitude of 
the oscillation allows the tip to contact the surface through the adsorbed fluid layer without 
getting stuck (91). 
For the morphology of fibrils grown at lipid bilayer interface, sample probes were 
taken from ATR-FTIR trough, and dissolved in chloroform to remove the lipids fraction 
from the probes. About 20 µL of sample were taken from the water soluble part and spin-
coated on the freshly cleaved mica. Thereafter, it was freeze-dried in a lyophilizer prior to 
make any AFM scan of the samples. Samples from monolayer lipid samples were directly 
taken from the interface, coated on freshly cleaved mica and dried before doing any AFM 
scan. For the cross-seeding and SDS experiments, the diluted reaction mixtures were spin-
coated on freshly cleaved mica and freeze-dried, prior to make any AFM scan. 
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Chapter 3. Results and discussion 
 
3.1. The effect of membrane-mimicking surfactant, SDS on proIAPP fibrillation 
Sodium dodecyl sulfate, SDS, is an anionic detergent, which has often been used as a 
membrane-mimicking agent (94-96). In phosphate buffer, pH 7.4, it exists either in a 
monomeric conformation or in a micellar conformation, depending on its concentration 
(97); at micromolar concentrations, SDS is known to interact with peptides and to induce 
order in the secondary conformation of the initially unordered peptides (98, 99). Because of 
its mesophasic behaviour, the different conformations adopted by SDS below, near, and 
above the critical micelle concentration, CMC (known to be 8 mM in water; addition of 
salts, in this case 10 mM phosphate, lowers the CMC (97)), could affect peptides differently 
(Figure 21). 
 
 
Figure 21: The diagram depicts the different conformations (mesophasic behaviour) attained at different 
concentrations of a surfactant in solution, i.e., monomers below the CMC, premicelles near the CMC, micelles 
above the CMC (adopted from Cui, et al. (100)). 
 
To understand the membrane’s effect on amyloidogenic peptides, with regards to their 
propensity to form amyloid fibrils inside the cells, they have been well-studied in the 
presence of SDS (50, 101, 102). In addition, the mesophasic nature and the simple 
chemistry of SDS molecules provides some vital information that can help in understanding 
the process in the process of more complex molecules or surfaces like non-esterified fatty 
acids or negatively charged phospholipid membranes, respectively (101). The effects of 
SDS on amyloid fibril formation vary, depending upon the concentration of SDS. SDS at 
sub-micellar concentrations has been shown to induce spherical aggregates (50), and is also 
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known to induce helical-rich conformation, which in turn may undergo conformational 
transitions to cross β-sheet conformations (102). The interactions of SDS with highly 
amyloidogenic peptides has been studied well above the CMC in order to provide structural 
insights of micelles bound to amyloidogenic peptide by NMR (103). However, to the best 
of our knowledge, there are no reports regarding the interactions of SDS or membranes 
except for this work or proceeding works done for this PhD thesis. The effects of various 
SDS concentrations, below or near the CMC, on the conformational transitions and the 
amyloidogenic propensity of proIAPP have been explored. To this end, combined 
methodological approaches, including fluorescence and circular dichroism spectroscopy, as 
well as tapping-mode atomic force microscopy have been used, as described in the 
subsequent sub-chapters. 
 
3.1.1. Circular dichroism spectrometry study (conformational changes in proIAPP in 
the presence of SDS) 
SDS is known to interact with proteins and peptides and to induce α-helical 
conformations (98). One of the most suitable techniques to follow changes in secondary 
structure is far-UV CD spectroscopy. CD spectra were recorded for 10 µM proIAPP in the 
presence of varying concentrations of SDS at the conditions described in the respective 
figure captions. To observe the effect of SDS on the conformational transition to amyloid 
fibrillar structures, different concentrations (0 µM, 100 µM, 0.5 mM, 1 mM) of SDS were 
used. The concentration of SDS at well-above the CMC is known to cease the 
amyloidogenic propensity of highly amyloidogenic peptides (96). Since the purpose was to 
study the effects of SDS on amyloidogenic propensity of proIAPP, SDS concentrations 
well-above the CMC were avoided for the study of proIAPP; proIAPP in bulk solution does 
not show any amyloidogenic character.  
ProIAPP in the absence of SDS shows a CD peak minimum at 201 nm and a shoulder 
at ~ 225 nm, confirming random coil as a predominant monomeric starting structure (Figure 
22). Moreover, the deconvolution results with the CDNN program reveal that proIAPP has 
a high population of disordered secondary structure element, approximately 40% random 
coil and 30% turns, as shown in the inset of Figure 22. Additionally, there has neither been 
any significant decrease in the ellipticity at 201 nm, nor any peak change from 201 nm to 
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216 nm, when recording CD spectra over 143 h under the experimental conditions used. 
Thus, proIAPP does not show any amyloidogenic propensity to aggregate or fibrillate in the 
absence of SDS, as observed by these time dependent CD spectroscopic measurements. 
 
 
 
Figure 22: Ellipticity spectra as monitored by CD spectroscopy for 10 µM proIAPP in 10 mM phosphate 
buffer, pH 7.4, at 25 °C. The inset shows the change in secondary structure content, deconvoluted using the 
CDNN program for the wavelength range 195 - 260 nm. 
 
In the presence of 100 µM SDS, there is a small but significant induction of ordered 
secondary structures in the initially unordered conformation as observed in the CD spectra 
measured over five days (Figure 23). The negative ellipticity peak that is present at ~ 201 
nm in the absence of SDS shifts to ~ 205 nm in the presence of 100 µM SDS, whereas the 
ellipticity at ~ 222 nm is more prominent than without SDS. The CDNN deconvolution of 
temporal CD spectra proves that SDS at this concentration induces ordered secondary 
structures to some extent (~ 8%), as it is generally known for. This partially folded 
conformation seems to undergo precipitation, as concluded from the decrease in the 
ellipticity at 205 nm with time. However, proIAPP in the presence of 100 µM SDS did not 
show any conformational transition in the ellipticity peak to 216 nm, the signature peak 
transition in the case of amyloid fibril formation, but the deconvolution using the CDNN 
program shows a small change in conformation from random coil to antiparallel β-sheet 
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(inset of Figure 23), indicating the accumulation of some conformations that are rich in 
antiparallel β-sheet conformations. 
 
 
 
Figure 23: Ellipticity spectra as monitored by CD spectroscopy for 10 µM proIAPP in the presence of 10 mM 
phosphate buffer, pH 7.4, containing 100 µM SDS at 25 °C. The inset shows the change in secondary 
structure content, deconvoluted using CDNN for the wavelength range 195 - 260 nm. 
 
Upon further increase in SDS concentration to 0.5 mM, an ellipticity peak at 208 nm 
appeared along with another peak at ~ 222 nm that are typical signatures for α-helical 
conformations (Figure 24). This shows that proIAPP attained a predominantly α-helical 
conformation at 0.5 mM SDS concentration, whereby 100 µM SDS was unable to induce α-
helical structures in the initially unordered conformation. Similar to the proIAPP fibrillation 
reaction containing 100 µM SDS, the solubility of monomeric proIAPP molecules 
decreased within the first 17 h of incubation in the presence of 0.5 mM SDS, as observed 
by the decrease in the ellipticity of the CD spectra recorded. This decrease occurs also 
without a subsequent transition of the ellipticity peak. However, the deconvolution of the 
time dependent CD spectra shows that this decrease in the ellipticity is accompanied by a 
loss in α-helical conformation and subsequent gain in corresponding antiparallel β-sheet 
structures (inset of Figure 24). 
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Figure 24: Ellipticity spectra as monitored by CD spectroscopy for 10 µM proIAPP in the presence of 10 mM 
phosphate buffer, pH 7.4, containing 0.5 mM SDS at 25 °C. The inset shows the changes in secondary 
structure content, deconvoluted using CDNN for the wavelength range 195 - 260 nm. 
 
Further increase in SDS concentrations to 1 mM SDS leads to a more prominent 
contribution of α-helical structures that are resistant to precipitation into insoluble 
structures, as shown in Figure 25. The ellipticity of proIAPP in 1 mM SDS neither 
decreases nor undergoes a transition to 216 nm with time. Furthermore, the deconvolution 
using the CDNN program is also unable to reveal any inter-conversion of secondary 
structure elements (inset in Figure 25). Hence, at this SDS concentration, a relatively large 
population of proIAPP molecules attains α-helical conformations on interaction with SDS 
micellar conformation. 
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Figure 25: Ellipticity spectra as monitored by CD spectroscopy for 10 µM proIAPP in the presence of 10 mM 
phosphate buffer, pH 7.4, containing 1 mM SDS at 25 °C. The inset shows the change in secondary structure 
content, obtained by deconvolution using the CDNN program for the wavelength range 195 - 260 nm. 
 
Thus, proIAPP does not undergo any prominent conformational transition under these 
conditions, a decrease in ellipticity is observed in the CD spectra at 0.1 mM SDS and 0.5 
mM SDS, only. 
 
3.1.2. Thioflavin T binding assay 
As described in the section for materials and methods, Thioflavin T (ThT) is an 
amyloid specific dye, which upon binding to amyloid fibrils exhibits a typical excitation 
maximum at ~ 440 nm and an emission maximum at ~ 482 nm (70). Additionally, the fibril 
formation occurs simultaneously with ThT binding; this characteristic of ThT is used to 
follow the kinetics of fibril formation by following the emission intensity at 482 nm by 
fluorescence spectroscopy. Generally, fibril formation is accompanied by a slow nucleation 
rate, followed by a fast elongation phase and finally a stationary phase. These three phases, 
when put together, represent the sigmoidal kinetics observed for ThT binding to fibrils (57). 
The ThT emission intensity at 482 nm is constant with time (up to 170 h) for 10 µM 
proIAPP for the condition mentioned in the figure legend of Figure 26. A varying SDS 
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concentration in the reaction buffer leads to a distinguished change in ThT emission 
intensity at 482 nm, i.e., the amyloidogenic propensity of proIAPP. However, this change in 
ThT intensity is observed only for a very small range of SDS concentrations in the reaction 
buffer. 
 
 
 
Figure 26: Kinetics of 10 µM proIAPP amyloid fibril formation carried out in 10 mM phosphate buffer 
containing 10 µM ThT, pH 7.4, at 25 °C, in the presence of 0 µM SDS (solid red cube), 100 µM SDS (solid 
black star), 0.5 mM SDS (solid blue triangle), 1 mM SDS (inverse dark cyan triangle) and 10 mM SDS (solid 
dark yellow tilted triangle). 
 
Starting with a tenfold higher molar ratio of SDS:proIAPP, proIAPP shows a slight 
increase in ThT emission intensity at 482 nm. This increase was not accompanied by any 
lag phase and the intensity of the stationary phase was only ca. 12% of the highest intensity 
observed for the same concentration of proIAPP in the presence of 1 mM SDS (Figure 26). 
At a fiftyfold higher molar ratio, i.e. 0.5 mM SDS in 10 µM proIAPP, a kinetic profile with 
a distinguished exponential growth phase and without lag phase was recorded (Figure 26). 
ProIAPP reaches the stationary phase within 2 h. However, the emission intensity is 
approximately 70% of the highest intensity observed in the presence of 1 mM SDS, only. 
Thus, the fibril formation observed in the presence of 100 µM and 0.5 mM SDS does not 
accompany any nucleation phase (Figure 26). Moreover, at a hundredfold higher molar 
ratio, i.e. 1 mM SDS in 10 µM proIAPP, a long lag phase of 58 h is observed, followed by 
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a well-defined exponential growth phase. A further increase in SDS concentration to 10 
mM does not show any effect on the fibrillation of 10 µM proIAPP within the time frame 
of the experiment (170 h of monitoring the ThT fluorescence kinetics) as shown in Figure 
26. Hence, proIAPP shows a maximum amyloidogenic propensity in the presence of 0.5 
mM SDS, with relatively rapid fibrillation kinetics. However, in terms of final ThT 
emission intensity at 482 nm, 1 mM SDS is more efficient in transforming proIAPP 
molecules into amyloid fibril structures. 
 
3.1.3. AFM study 
Atomic force microscope (AFM), as described in the materials and methods section, 
is used for the characterization of surface morphology. Samples were taken from the 
respective reaction mixtures where the ThT kinetics reached the stationary phase. 
Thereafter, the spin-coating method was used to prepare the sample for the AFM scan, 
followed by freeze-drying, which guarantees a minimum time to dry, thus minimize 
surface-induced aggregation effects. The morphologies of the spin-coated samples on the 
mica surfaces are consistent with the corresponding fibrillation kinetics. 10 µM proIAPP do 
not show any oligomeric/protofibrillar/fibrillar morphology in the AFM scan in the absence 
of SDS and in the presence of 10 mM SDS. Samples from the 0.1 mM SDS reaction 
solution display oligomeric conformations with heights of 2 - 3 nm (Figure 27, left). 
 
       
 
Figure 27: AFM images of proIAPP amyloid fibrils formed in the presence of 100 µM SDS (left) and 0.5 
mM SDS (right). 
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AFM samples prepared from the stationary phase of proIAPP fibrillation containing 
0.5 mM SDS show short and twisted protofibrils with a height of 3 - 4 nm, only (Figure 27, 
right). Although samples from the stationary phase of the proIAPP fibrillation kinetics in 
the presence of 1 mM SDS show typical long fibrils with a height of 3 - 4 nm in the AFM 
(Figure 28), no fibrillar morphology was observed for the samples prepared from proIAPP 
fibrillation reaction mixture containing 10 mM SDS. 
 
 
 
Figure 28: AFM image of proIAPP amyloid fibrils formed in the presence of 1 mM SDS. 
 
3.1.4. Discussion (SDS effects on proIAPP fibril formation) 
ProIAPP is known to be the least amyloidogenic polypeptide among the processing 
intermediate polypeptides during IAPP synthesis in pancreatic β-cells (17). The least 
amyloidogenic propensity of proIAPP has been explained by the presence of positively 
charged N- and C- termini, directly flanking the primary sequence of the highly 
amyloidogenic polypeptide IAPP (17, 18). Moreover, the N-terminal extended proIAPP 
fragment has been shown to interact with negatively charged surfaces present inside the 
pancreatic β-cells (21). Thus, the hypothesis has been put forward that proIAPP might be 
involving in the onset of T2DM through intracellular amyloid fibril formation via 
interaction with these negatively charged cellular moieties (21). However, the factors that 
govern the formation of this intracellular amyloid are still unclear. Since very little is 
known about the amyloidogenic propensity of proIAPP, because of its non-amyloidogenic 
nature in vitro, it was advisable to select a simple negatively charged surface to study the 
possible underlying mechanism of intracellular amyloid fibril formation of proIAPP. On the 
 58 
 
other hand, sodium dodecyl sulfate (SDS) has been well established as a membrane-
mimicking agent to reveal the influence of simple negatively charged membranes on 
amyloidogenic peptides (94, 95). SDS attains different conformations in the reaction buffer, 
depending upon the concentration of SDS, i.e. below and above the critical micelle 
concentration (CMC). Thus, the different concentrations of SDS have shown different 
effects on the fibrillation kinetics of proIAPP as well as on the fibrillar morphology of 
proIAPP. Here, proIAPP does not show any amyloidogenic propensity in the absence of 
SDS for the measured period of time and conditions, i.e., no conformational transition or 
significant decrease in ellipticity by CD (Figure 22), neither an increase in ThT emission 
intensity at 482 nm (Figure 27), nor any oligomeric/protofibrillar/fibrillar morphologies by 
AFM have been observed. Freshly dissolved proIAPP exhibits predominantly a random coil 
conformation. However, addition of SDS to the reaction buffer induces ordered secondary 
structures as well as amyloidogenic propensity in proIAPP. The range of SDS 
concentrations that could induce the amyloidogenic propensity in proIAPP was found to be 
narrow under the experimental conditions chosen, i.e., 0.1 – 1.0 mM only, while the 
concentration which was able to induce an α-helical conformation in proIAPP was 0.5 mM 
SDS or above. Moreover, no conformational transition was detected by CD spectroscopy. 
In the cases of aggregation, only a significant decrease in ellipticity was observed (Figure 
23-25). Additionally, proIAPP in the presence of 0.5 mM SDS was able to show some 
conformational transition from α-helix to β-sheet after deconvolution, only (inset of Figure 
24). 
SDS at a 100 µM concentration was the first one to induce an amyloidogenic 
propensity in proIAPP, however, to some extent, only. At 0.5 mM, SDS was able to induce 
a marked amyloidogenic propensity in proIAPP, as observed in the ThT binding kinetics 
(Figure 26). This observation can be rationalized by the presence of positively charged 
residues at the N- and C- termini of the highly amyloidogenic motif of proIAPP. To screen 
the electrostatic repulsion between these positively charged residues, an optimum 
concentration of SDS was needed. At 0.5 mM SDS, proIAPP showed a typical fibrillation 
kinetics, accompanied by a well distinguished exponential phase but without any lag phase. 
ProIAPP fibrils only attain oligomeric and protofibrillar conformations in the presence of 
0.1 and 0.5 mM SDS, respectively. These findings may have special significance in vivo, 
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possibly seeding the IAPP and insulin fibrillation (Chapter 3.4). Moreover, a 1 mM SDS 
concentration was able to induce amyloidogenic propensity in proIAPP, as observed by a 
well pronounced ThT kinetics with a relatively long lag phase followed by an exponential 
growth phase (Figure 26), and a matured fibrillar morphology with fibrillar heights of 3 - 4 
nm (Figure 28). This indicates that the gradual appearance of micelles around the CMC (the 
CMC for SDS in water is 8 mM, adding salts decreases the CMC) imposes a certain steric 
hindrance in the self-assembly of peptide molecules into oligomers, thus a long lag phase 
was observed in the presence of 1 mM SDS. However, once the nuclei/oligomers were 
established, the highest increase in fluorescence emission intensity at 482 nm was observed. 
10 mM SDS (above the CMC) was unable to induce amyloidogenic propensity in proIAPP, 
either because of the absence of monomeric conformations of SDS to screen the 
electrostatic repulsion between residues of adjacent peptide molecules or the interaction 
between SDS micelles and proIAPP is imposing a certain steric hindrance, thus prolonging 
the time scale of nuclei/oligomers formation beyond the time frame of our study at this 
concentration. 
Thus, these results show that SDS affects the conformation and the amyloidogenic 
propensity of proIAPP. Below the CMC, SDS enhances the proIAPP fibrillation mainly by 
screening the electrostatic repulsion, while near the CMC the appearance of micellar 
structures of SDS decreases the rate of nucleus formation by partitioning of the monomeric 
proIAPP population inside micelles. Micelles, upon binding to proIAPP, are able to induce 
an α-helical conformation in the proIAPP. SDS above the CMC is able to diminish the 
amyloidogenic propensity of proIAPP by binding to the peptide molecules, thus inhibiting 
the proximity of another peptide molecule via steric hindrance, hence inhibit the self 
assembly of proIAPP into amyloid fibrillar structures. 
 
3.2. The effect of lipid monolayers on proIAPP fibrillation 
After establishing the amyloidogenic propensity of proIAPP in the presence of 
negatively charged surfactant (SDS), our focus shifted towards the study of the 
conformational changes in proIAPP upon interaction with model lipid monolayer 
membranes. The physiologically active part of proIAPP, IAPP has been shown to insert 
itself as monomers into the lipid monolayer membranes with the help of the charged 
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residues present at the N-terminus of the peptide (23). This insertion of monomeric IAPP 
molecules enhanced the rate of IAPP amyloid fibril formation (22). Since proIAPP has a 
relatively higher number of positively charged residues at the N-terminus, the possibility of 
comparatively strong electrostatic interaction between proIAPP and negatively charged 
monolayer membranes might play an important role in the amyloid fibril formation of 
otherwise non-amyloidogenic proIAPP. To address this point, we tried to study the 
conformational dynamics of proIAPP and its mutant, proIAPPSer13, 18, upon interaction with 
negatively charged lipid monolayers (POPG) at different initial surface pressures, i.e., 16 
mN/m, 20.5 mN/m (for mutant proIAPP, only) and 31 mN/m, respectively, by employing 
methodologies like IRRAS and AFM. 
 
3.2.1. IRRAS study 
As mentioned in the materials and methods section, IRRAS is the most suitable 
technique for the study of lipid-peptide interactions by analysis of the contours of the 
amide-I and -II bands. Here, proIAPP and mutant proIAPP (proIAPPSer13,18) interactions 
with a negatively charged lipid monolayer, POPG, were studied. First, we studied the 
interaction of 1 µM proIAPP with negatively charged lipid monolayers of POPG at a 
surface pressure of 16 mN/m. As shown in the inset of Figure 29, the increase in surface 
pressure was observed immediately after addition of the POPG solution onto the subphase 
containing 1 µM proIAPP. This increase in surface pressure was accompanied by two 
phases, one exponentially increasing phase, reaching a surface pressure of ~ 21 mN/m 
within first hour of the injection of POPG, and another very slow, non-stop increasing 
phase, with the surface pressure reaching ~ 24.5 mN/m in the next ~ 22 h of measurement 
(inset of Figure 29). 
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Figure 29: IRRA spectra of the amide-I’ regions of POPG monolayers with 1 µM proIAPP at the respective 
positions of the surface-pressure versus time curve shown in the inset, with an initial surface pressure of ~ 16 
mN/m. 
 
The wavenumbers of the amide-I’ band with initial values of ~ 1658 cm-1, typical for 
α-helical conformations, remained constant with a slight increase in the intensity, during the 
exponential increase in surface pressure. However, the slowly increasing surface pressure 
curve was accompanied by a decrease in the intensity of the amide-I’ band at ~ 1658 cm-1. 
The IRRA spectra measured after ~18 h of the lipid injection onto the subphase show an 
amide-I’ band of positive intensity with a shift of 8 cm-1, i.e., at ~ 1650 cm-1 (Figure 29). 
The packing density of lipids in biological bilayer membranes corresponds to a 
surface-pressure of ~ 30 - 35 mN/m (104). Thus, in order to check the ability of proIAPP to 
insert into bilayer membranes, the conformational dynamics and adsorption isotherm were 
measured at an initial surface-pressure of 31 mN/m. At this surface pressure, two positive 
peaks in the amide-I’ band region, corresponding to 1646 and 1685 cm-1, appeared (Figure 
30). However, there was a significant increase (~ 10 mN/m) in the surface pressure upon 
injection of POPG solution onto the subphase containing 1 µM proIAPP (inset of Figure 
30). The 10 mN/m increase of surface pressure strongly suggests that proIAPP is able to 
insert into the POPG membrane, as has been shown with the physiologically active peptide 
IAPP, which inserts into biological membranes in vivo (22). 
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Figure 30: IRRA spectra of the amide-I’ region of POPG monolayers with 1 µM proIAPP at the respective 
positions of the surface-pressure versus time curve shown in the inset, with an initial surface pressure of ~ 31 
mN/m. 
 
At this initial surface pressure of 30 mN/m, proIAPP consist of a major population of 
random coil conformation with some percentage of turns with bands at ~ 1647 and 1685 
cm-1 (Figure 30). These two IR peaks merged into one broad peak with center at ~ 1666 cm-
1
, with time and increasing surface pressure. 
The interaction of mutant proIAPP, proIAPPSer13, 18, interaction with lipid monolayers 
was also studied. Interestingly, the replacement of Cysteine 13 and 18 of proIAPP with 
serine had an impact on the insertion kinetics of proIAPP. At the initial surface pressure of 
~ 20 mN/m, proIAPPSer13,18 adsorbs immediately at the POPG-D2O interface, as concluded 
from the exponential increase in the surface pressure immediately after the addition of 
POPG solution onto the subphase containing 1.66 µM proIAPP (inset of Figure 31). 
However, the increase in surface pressure was not so prominent for proIAPP adsorption at 
an initial surface pressure of 16 and 31 mN/m. ProIAPPSer13, 18  attains a conformation rich 
in α-helix content, upon adsorption to the lipid-D2O interface (Figure 31). After 3 h of 
injection of the POPG solution onto the subphase, the surface pressure reached 25.5 mN/m 
but the conformation of the mutant proIAPP (proIAPPSer13, 18) remained constant without 
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any conformational transition or decrease in intensity of the amide-I’ band (Figure 31); 
however, proIAPP at 25 mN/m had already diffused to the reference trough, which resulted 
in net positive amide-I’ band (Figure 29). 
 
 
 
Figure 31: IRRA spectra of the amide-I’ region of POPG monolayers with 1.66 µM proIAPPSer13, 18, at the 
respective positions of the surface-pressure versus time curve shown in the inset, with an initial surface 
pressure of ~ 20 mN/m. 
 
3.2.2. AFM study 
Atomic force microscope (AFM) has been used here to characterize the morphology 
of the surface containing samples from the sample trough as well as the reference trough of 
the IRRAS experiments. 5 µL of the samples from the interface of lipid-D2O of the sample 
trough and air-D2O of the reference trough were applied onto freshly cleaved muscovite 
mica and allowed to dry at ambient temperature. Fibrillar morphologies with a height of 3 - 
5 nm were found in both samples of 1 µM proIAPP at initial surface pressures of ~ 16 
mN/m and 31 mN/m, respectively (Figure 32). However, the proIAPPSer13, 18 samples 
collected from the air-D2O and POPG lipid monolayer-D2O interface of the sample and 
reference trough, respectively, did not show any fibrillar-like morphology. Interestingly, the 
fibrils formed at an initial surface pressure of 31 mN/m were densely grown in comparison 
to the fibrils formed at an initial surface pressure of 16 mN/m (Figure 32). 
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Figure 32: Representative AFM image of proIAPP (1 µM) amyloid fibrils, formed at the POPG-D2O 
interface (sample trough) and air-D2O interface (reference trough) at a surface pressure of 16 mN/m (left 
panel) and 31 mN/m (right panel), respectively. 
 
3.2.3. Discussion 
In this study, the IRRAS methodology was used to explore the effect of lipid 
monolayers on the conformational properties and amyloidogenic propensity of proIAPP at, 
below and near the intracellular membrane’s lateral pressure. ProIAPP shows a similar 
adsorption isotherm as shown by its physiologically active part, IAPP, upon interaction 
with negatively charged lipid monolayers (22). The increase in lateral pressure is not that 
prominent, but it is significant (> 8 mN/m), independent of the initial lateral pressure of the 
lipid monolayers (16 and 31 mN/m, respectively), indicating that proIAPP is inserting into 
the lipid monolayers. The insertion of proIAPP into the POPG monolayers is not 
accompanied by any conformational transition, in contrast to what has been observed for 
IAPP upon insertion into lipid monolayers (22). Interestingly, the absorbance of the amide-
I’ band decreases with time, which could have the following reasons: 
1) The peptide undergoes a conformational transition, i.e., from α-helix (1658 cm-1) 
to another conformation. 
2) The peptide undergoes an orientational change during its aggregation at the lipid-
D2O interface. 
3) The peptide diffuses spontaneously to the reference trough. 
Since time dependent IRRA spectra did not show any conformational transition, the 
first possibility can be ruled out. Additionally, the IRRA spectra which were measured with 
40° p-polarized light indicate that the second possibility of an orientational change can also 
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be excluded as potential reason for the decrease in absorbance of the amide-I’ band. Hence, 
the third possibility remains the only reason to describe the decrease in absorbance of the 
amide-I’ band with time. The phenomenon of spontaneous diffusion was later confirmed by 
the AFM images; AFM images of samples from interfaces of the sample and reference 
trough show fibrillar morphology, indicating diffusion of peptides to the reference trough 
took place. Moreover, peptides have been shown to diffuse spontaneously to the reference 
trough despite insertion into the lipid monolayer (22). 
The IRRA spectra presented originate from the difference between the absorbance of 
p-polarized infrared light by the surface of the reference and sample trough, respectively. 
Thus, if any conformational changes occur in the sample trough due to fibril formation at 
the lipid interface, it may have been subtracted to null by the conformational changes 
happening in peptides that diffused to the reference trough. Moreover, at a 31 mN/m initial 
lateral pressure of the lipid monolayers, the IRRA spectra were showing a positive amide-I’ 
band absorbance from the very beginning, indicating that the major population of proIAPP 
has already diffused to the reference trough. This reflects the fact that a certain surface 
pressure value is needed for spontaneous diffusion of proIAPP to the reference trough. 
Based on these observations, we can conclude that: 
1) ProIAPP inserts into negatively charged lipid monolayers. 
2) The insertion induces an α-helical conformation in proIAPP. 
3) After a certain time or/and a certain surface pressure, the major population of the 
proIAPP molecules diffuses to the reference trough, and only a small fraction of 
the peptide molecules interacts/inserts into the lipid monolayers, as shown by the 
slow increase of the surface pressure in the late phase of the adsorption isotherm. 
 
To conclude, the insertion of proIAPP into lipid monolayers induces the folding of 
proIAPP to an α-helix rich conformation, which undergoes amyloid fibril formation. 
Furthermore, the diffusion of aggregated amyloid fibrils from the subphase/interface of the 
sample trough to the reference trough most likely accounts for the observed positive amide-
I’ band. Interestingly, SDS at micellar concentrations induced a similar effect in proIAPP, 
i.e., a conformational switch from random coil to α-helix. Thus, it can be concluded that 
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proIAPP attains an α-helical rich conformation upon binding/insertion into negatively 
charged lipid-like (SDS)/lipid (POPG) interfaces, before it finally starts to fibrillate. 
 
3.3. The effect of lipid bilayer membranes on proIAPP fibrillation 
The prediabetic stage of T2DM is accompanied by higher insulin needs, which in turn 
triggers the release of premature secretory granules through secretagogue stimulation, 
containing a higher amount of unprocessed prohormones (proIAPP and proinsulin). 
Furthermore, increased levels of free fatty acids have been observed in the prediabetic stage 
of T2DM (20). It has been shown that the β-cells exposed to hyperlipidaemia remodulate 
their membranes by increasing the negatively charged lipid content (105-107). In the 
prediabetic stage, the anionic lipid content of the membrane seems to increase beyond the 
physiological range, i.e. > 10 - 30%. In fact, it has been shown that the processing 
intermediates of proIAPP bind strongly to the membranes that have more than 30% anionic 
lipids, and this binding increases the amyloid fibrillation rate significantly (51). Thus, the 
purpose of this part of the thesis was to: 
1) explore the amyloidogenic propensity and conformational properties of human 
proIAPP in the presence of negatively charged membrane surfaces, which are 
abundant in cellular environments of the prediabetic stage. 
2) reveal the mechanism of proIAPP aggregation/fibrillation reaction in the 
absence and presence of these anionic and various other membrane systems, 
including heterogeneous model raft mixtures. 
 
The effect of proIAPP on IAPP fibrillation in the presence of lipid membranes has 
been investigated. To this end, a combined spectroscopy and microscopy approach has been 
applied using CD, fluorescence and ATR-FTIR spectroscopy as well as AFM. 
 
3.3.1. CD and ATR-FTIR spectroscopy study 
The starting conformation of proIAPP was investigated by dissolving 10 µM proIAPP 
in phosphate buffer via CD or FTIR spectroscopy, respectively. The CD spectra exhibit a 
minimum at ~ 201 nm along with a shoulder at ~ 220 nm (Figure 33), indicating that 
proIAPP has a predominantly random coil conformation (~ 37%, as found by the CDNN 
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fitting program, inset of Figure 33) along with some regular secondary structure elements 
as the starting conformation. 
 
 
Figure 33: CD spectra of 10 µM proIAPP dissolved in 10 mM phosphate buffer, pH 7.4, at 25 °C. The inset 
shows the percentages of different secondary structures as obtained by the CDNN program (wavelength range 
200 - 260 nm). 
 
 
 
Figure 34: Secondary structure elements of the native structure of proIAPP dissolved in 10 mM phosphate 
buffer, pD 7.4, at 25 °C, as obtained by analysis of the FTIR data. 
 
 68 
 
The FTIR spectrum of the native form of proIAPP (10 µM) was recorded to have a 
comparison with the ATR-FTIR data of the system containing the solid supported lipid 
bilayer membranes. Each spectrum was fitted multiple times with a similar set of sub-bands 
and slight variations of the starting conditions. Figure 34 shows the results of the fit 
including the corresponding error bars. Comparison of the secondary structure contents 
shows that proIAPP has predominantly unordered and turn structures. 
 
3.3.2. Thoflavin T binding assay 
As described in the previous chapters, Thioflavin T is used as amyloid specific dye to 
follow the fibrillation kinetics using fluorescence spectroscopy. The increase in the ThT 
emission maxima at 25 °C is monitored with time for 10 µM and 40 µM proIAPP, 
respectively, in the presence of DOPC:DOPG (7:3, w/w) as depicted in Figure 35 (for 10 
µM proIAPP, no aggregation is observed over the time span shown). The fibrillation 
kinetics follows a nucleation dependent aggregation mechanism which includes a lag phase 
accompanied by nuclei formation, followed by an exponential growth phase and then a 
stationary phase, as shown in Figure 35. The lag phase is generally used to define the 
amyloidogenic propensity of a protein or peptide. The shorter the lag phase, the more 
amyloidogenic is the protein. As shown in Figure 35, 10 µM proIAPP does not show an 
increase in ThT intensity at 482 nm within the time frame of the measurement. However, 
the increase in concentration of proIAPP to 40 µM results in a lag phase of ~ 38 h followed 
by an exponential growth phase for ~ 2.5 h. 
The data (Figure 35) clearly show that the presence of the anionic DOPC:DOPG (7:3, 
w/w) membrane triggers the fibrillation process of proIAPP, but above a critical 
concentration only. In the absence of the lipid bilayer, no aggregation has been observed up 
to 7 days even for 40 µM proIAPP at 25 °C. Within the same time period, aggregation of 
proIAPP was also not observed at membranes with significantly less anionic lipid contents, 
such as DOPC:DOPG ratios of 9:1 and 8:2, a pure zwitterionic (DOPC) lipid bilayer and at 
the DPPC:DOPC:cholesterol (1:2:1) model raft mixture. 
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Figure 35: Thioflavin T – monitored amyloid fibril formation kinetics of 10 µM proIAPP (open red triangle), 
and of 40 µM proIAPP (open center dot blue star) in the presence of DOPC:DOPG (7:3, w/w) lipid vesicles. 
The experiments were carried out in 10 mM phosphate buffer, pD 7.4, at 25 °C. 
 
Lastly, ThT measurements were also applied to observe the effect of the presence of 
proIAPP on the amyloidogenic propensity of human IAPP. Two molar ratios of proIAPP 
and hIAPP, 10 µM : 10 µm and 30 µM : 10 µM, were used, respectively (Figure 36). The 
ThT kinetics study for these mixtures with a mixing time of 4 min shows aggregation, but 
with prolonged lag phases compared to the pure hIAPP solution (Figure 36). 
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Figure 36: Thioflavin T – monitored amyloid fibril formation kinetics of 10 µM hIAPP (close black 
rectangles), 10 µM proIAPP (open red triangle), 10 µM proIAPP + 10µM hIAPP (magenta cross), 30 µM 
proIAPP + 10 µM hIAPP (close dark green triangle), and 40 µM proIAPP (open center dot blue star) in the 
presence of DOPC:DOPG (7:3, w/w) lipid vesicles prepared in 10 mM phosphate buffer, pD 7.4, at 25 °C. 
 
3.3.3. ATR-FTIR spectroscopy study 
The conformational changes of proIAPP were also studied in the presence of lipid 
interfaces at 25 °C using the ATR-FTIR spectroscopy. To evaluate the changes in 
secondary structure of proIAPP at the membrane interface supported on the IRE (internal 
reflection element)-crystal (Ge, germanium), we collected ATR-FTIR spectra over an 
interval of 30 min for 7 days after the injection of a 40 µM proIAPP solution into the ATR-
cell (a 10 µM proIAPP solution did not show any amyloidogenic propensity at the 
membrane interface, Figure 35). Due to interfacial adsorption, the local concentration close 
to the IRE crystal surface and membrane increased with time, hence also the FTIR 
intensity. Subsequently, this adsorption was followed by an aggregation process. During the 
aggregation process, the peak maximum of the amide-I’ band of proIAPP shifted from 1644 
cm-1 to 1628 cm-1. Figure 37 shows selected ATR-FTIR spectra of the time-dependent 
measurement, while Figure 38 represents normalized selected spectra. 
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Figure 37: Time evolution of the amide-I’ band of proIAPP upon adsorption at the DOPC:DOPG (7:3, w/w) 
membrane interface supported on an IRE crystal in the ATR-cell at 25 °C. 
 
 
 
Figure 38: Time evolution of the normalized amide-I’ band of proIAPP upon adsorption at the DOPC:DOPG 
(7:3, w/w) membrane interface. 
 
The arrow in Figure 37 shows the gradual increase in amide-I’ band intensity and shift 
upon adsorption to the membrane interface, while the arrows in Figure 38 depict the 
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decrease in the intensity of the amide-I’ band at ~ 1647 cm-1 and the concomitant increase 
in the intensity at ~ 1628 cm-1 band over the time period measured. 
 
 
 
Figure 39a: Fourier self-deconvolution (FSD) spectra of the amide-I’ band of proIAPP upon adsorption at the 
DOPC:DOPG (7:3, w/w) membrane interface. 
 
 
 
Figure 39b: Second derivative spectra of the amide-I’ band of adsorbed proIAPP at the DOPC:DOPG (7:3, 
w/w) membrane interface. 
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Figures 39 a & b show the Fourier self deconvolution (FSD) and the second derivative 
data of time dependent spectra. They reveal seven distinct bands for native proIAPP, 
appearing at ~ 1678, 1674, 1665, 1657, 1647, 1641 and 1631 cm-1, respectively. During the 
aggregation process, some of the bands shift to higher wavenumbers and two strong bands 
at ~ 1628 and 1619 cm-1 appear. Thereafter, peak fitting of the normalized spectra was 
performed for quantitative analysis of the underlying secondary structural changes. 
Figure 40 shows the time evolution of the conformational changes within the first 40 
h obtained by fitting the normalized curves for the respective seven bands. It is clear from 
the peak fitting that the major conformational changes happened with bands corresponding 
to ~ 1660 (loop), 1647 - 1653 (α-helical), and 1617 (intermolecular β-sheet) cm-1. The 
bands corresponding to loops and α-helices followed a sigmoidal decrease, and the 
intermolecular β-sheet bands follow a sigmoidal increase with a lag phase of ~ 4 h 
respectively. Thus, proIAPP fibrillation at the DOPC:DOPG (7:3 w/w) membrane interface 
is accompanied by a decrease in loop and helical conformation and simultaneous gain in 
intermolecular β-sheet structural content. Besides intermolecular β-sheets, the 
intramolecular β-sheet (at 1635 cm-1) content increases slightly from 12 to 14% with time.  
 
 
 
Figure 40: Time evolution of the secondary structural changes upon fibrillation of 40 µM proIAPP on the 
DOPC:DOPG (7:3, w/w) anionic membrane interface, derived from peak-fitting of the normalized ATR-FTIR 
spectra. 
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To investigate the effect of varying lipid compositions, additional ATR-FTIR 
experiments on 40 µM proIAPP were performed in the presence of pure DOPC bilayers and 
of bilayers composed of a lipid raft mixture, DOPC:DPPC:Chol (1:2:1). Figures 41 and 42 
exhibit the time evolution of the corresponding amide-I’ bands.  
 
 
 
Figure 41: Time evolution of the amide-I’ band of proIAPP upon adsorption at the pure DOPC membrane 
over a period of 7 days at 25 °C. 
 
In case of pure DOPC (Figure 41), only adsorption of proIAPP at the membrane 
interface without any subsequent changes in amid-I’ band frequency was observed. 
However, adsorption at the raft mixture was accompanied by the appearance of a shoulder 
in the intermolecular β-sheet region after 3 days, which further evolved upto 7 days (Figure 
42). 
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Figure 42: Time evolution of the amide-I’ band of proIAPP upon adsorption at a heterogeneous raft 
membrane consisting of DOPC:DPPC:Chol (1:2:1) over the period of 7 days at 25 °C. 
 
Thus, the presence of a pure zwitterionic lipid bilayer membrane (DOPC) has no 
effect on the amyloidogenic propensity of proIAPP, while the heterogeneous raft membrane 
has a minor effect, only. The kinetics of aggregation at the heterogeneous raft membrane is 
very slow, and the aggregate structure does not seem to be well ordered. 
 Finally, we also checked the presence of proIAPP on the amyloidogenic propensity 
of human IAPP at the anionic DOPC:DOPG (7:3, w/w) interface. The adsorption kinetics 
of the hIAPP:proIAPP equimolar mixture is relatively slow in comparison to hIAPP (Figure 
43, upper panel), and the same holds true for the fibrillation kinetics (Figure 43, lower 
panel). Notably, the final adsorption and intermolecular β-sheet intensities are smaller for 
hIAPP in comparison to the peptide mixture, which could be attributed to a seed-induced 
co-fibrillation of the proIAPP. The longer lag and elongation phase of the proIAPP + IAPP 
mixture could be attributed to the interaction and complex formation between the highly 
amyloidogenic core of hIAPP and distinct regions, such as the pro-region, of the proIAPP 
molecules. 
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Figure 43: Upper panel: Adsorption kinetics of a mixture of hIAPP and proIAPP (1:1, each 10 µM) in the 
presence of an anionic (DOPC:DOPG, 7:3) membrane and of hIAPP under the same conditions, followed by 
integration of the amide-I’ band between 1710 and 1585 cm-1. Lower panel: Depicts the corresponding 
intermolecular β-sheet content with respect to the whole amide-I’ area of hIAPP and the equimolar mixture of 
hIAPP and proIAPP (10 µM each), in the presence of the anionic membrane. 
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3.3.4. AFM study 
Atomic force microscope (AFM) is used here to reveal the morphology of the protein 
aggregates, also in the presence of membraneous interfaces (22, 108). Here, the spin-
coating method is used to prepare the samples, followed by freezing and drying in a 
lyophilizer to decrease the drying time. This protocol for the AFM sample preparation 
minimizes the surface-induced aggregation effects. Unlike other membrane-induced 
fibrillating systems, such as hIAPP (22, 24, 109), proIAPP is found to form oligomeric or 
small fibrillar structures, only. Notably, there was no major spectral difference in the ATR-
FTIR data for these two peptides, hence the different aggregates (the large oligomeric vs. 
fibrillar ones) must essentially differ in the packing properties of the aggregating units, 
only. Figure 44 depicts characteristic AFM images of 40 µM aggregated proIAPP in the 
presence of the anionic lipid bilayer. Essentially oligomeric structures were found with 
heights in the range of 2.5 – 3.5 nm. Along with these oligomeric species, a minor 
population of small fibrillar structures having lengths of 50 – 55 nm was found as well. A 
similar analysis for 40 µM proIAPP in bulk solution under the same conditions up to seven 
days did not show either significant secondary structural changes (measured by ATR-FTIR 
spectroscopy) or changes in the morphology (determined by AFM). 
 
 
 
Figure 44: AFM image of proIAPP, aggregated at a concentration of 40 µM in the presence of the 
DOPC/DOPG (7:3 w/w) membrane at 25 °C for 7 days (left), and the corresponding height scale (right). 
 
3.3.5. Discussion 
The main focus of this part of the thesis was to reveal the time scale and underlying 
mechanisms of the fibril formation of proIAPP in the presence of lipid membranes. Besides 
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anionic membranes (DOPC:DOPG, 7:3), zwitterionic and model raft mixtures were also 
used as model membrane systems for the interaction studies. In fact, lipid membranes seem 
to constitute the preferred loci of aggregation and probably also of cytotoxicity (22, 24, 
109). The secondary structures of proIAPP were first determined after injection of the 
sample to capture their starting conformation, using CD and FTIR spectroscopy. Both 
methodologies present proIAPP as predominantly random coil structure with little 
percentage of ordered secondary structure content. 
The fibrillation kinetics monitored with the ThT assay (Figure 35) shows that 
proIAPP, which does not show any amyloidogenic propensity in the absence and in the 
presence of anionic membrane (DOPC:DOPG, 7:3) at lower concentration (< 40 µM), 
undergoes aggregation with a lag phase of ~ 39 h. Certainly, different lag and growth times 
are seen in different sample environments, such as in the ATR-cell, where the lag time for 
40 µM proIAPP was in the range of ~ 4 h in the presence of anionic lipid membrane. 
Differences in time scale are due to the difference sample geometry and vesicle 
preparations. In the presence of supported phospholipid bilayers (lipid bilayer on IRE 
crystal), the signal is due to the concentration increase of the peptides upon adsorption at 
the flat lipid interface, while in the ThT kinetic assay, the peptides interact with large 
spherical unilamellar vesicles (LUVs). Thus, a strong self association potential is achieved 
for proIAPP in the presence of anionic membranes. Nevertheless, proIAPP showed very 
low amyloidogenic propensity. This low amyloidogenic propensity of proIAPP may be 
rationalized by the increased net charge on the N- and C- termini in comparison to hIAPP 
(see Figure 2), which is known for its amyloidogenic propensity and shares its primary 
sequence with proIAPP (17). Moreover, Figure 37 reveals that when the proIAPP 
concentration at the anionic membrane interface exceeds a critical concentration (because 
of adsorption at the interface), the aggregation is observed by ATR-FTIR measurements. 
Thus, in proIAPP aggregation, the adsorption is the preceding step of the fibrillation 
process, followed by self-assembly of adsorbed proIAPP molecules at the anionic lipid 
interface (for a schematic representation of such mechanism, see Figure 6). Additionally, 
proIAPP does not adsorb and aggregate significantly in the presence of the pure 
zwitterionic fluid DOPC membrane within a time period of up to 7 days. Conversely, in the 
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presence of the zwitterionic but heterogeneous model raft membranes, proIAPP seems to 
cluster into less-ordered structures, with slower kinetics. 
Unlike other amyloidogenic peptides, proIAPP forms mainly small oligomeric-like 
disordered structures at the anionic lipid membrane interface, having heights of ~ 3.5 nm. 
These heights correspond to the heights of normal fibrils, which vary typically from 2 nm 
(in the case of hIAPP fragments (110, 111) and α-synuclein (112)) to 6 nm (e.g., for hIAPP 
(113), insulin (114, 115)). This difference in morphological structure of proIAPP may be 
attributed to the presence of the pro-region, i.e., its C- and N- termini flanking the 
amyloidogenic core, which largely corresponds to the primary sequence of the highly 
amyloidogenic hIAPP. It may be rationalized that due to these additional ends, efficient 
packing into ordered fibrillar structures is hampered, thus leading to the more disordered 
oligomeric aggregate structures observed by AFM for proIAPP. 
It was also observed that the addition of proIAPP to hIAPP delays the rate of hIAPP 
fibril formation, probably by some kind of complex formation. A 1:1 molar mixture of 
proIAPP and hIAPP increased the lag phase by a factor of ~ 3 h (Figure 36). Thus, it 
appears reasonable to speculate that the pro-region of the proIAPP prolongs the fibrillation 
kinetics of the highly amyloidogenic peptide, hIAPP. In fact, it has been speculated that 
part of the function of hIAPP processing intermediates, like proIAPP, may be to prevent 
aggregation and amyloidogenesis in the early stages of hIAPP biosynthesis and transport 
(17). Particularly, in the case of excess proIAPP, increased aggregation levels have finally 
been observed, which could be attributed to a seed-induced co-fibrillation of proIAPP. 
Reports on the aggregation of other systems where similar proteins have been compared, 
such as different insulin constructs or homologues of lysozyme (116, 117), are still scarce, 
so that generalizations are difficult to make. However, it is clear that seeding of peptide 
fibril formation depends strongly on the similarity of their sequences, which is largely 
fulfilled for hIAPP and its propeptide, proIAPP. 
 
3.4. The effect of seeds on the fibrillation of peptides secreted from pancreatic β-cells 
As mentioned in the introduction, the amyloid stability appears to be derived from a 
combination of forces, including but not limited to H-bonding, like the stabilizing forces of 
globular proteins. This includes the stacking of side chains from different peptides/proteins, 
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along with the H-bonding between backbones of different peptide molecules. It has been 
known that amyloidogenesis is an inherent property of proteins/peptides; even non-
amyloidogenic proteins/peptides undergo amyloid fibril formation under certain conditions. 
Thus, it is important to know how the seeds from one amyloidogenic peptide can affect the 
amyloidogenic propensity of other amyloidogenic or non-amyloidogenic peptides or 
proteins that are stored, processed, and secreted together. The seeds of Aβ fibrils have 
shown to modulate the fibrillation of IAPP and vice versa (118), while these two peptides 
are secreted by the distantly located organs of the human body. Hence, it seems reasonable 
to execute the cross-seeding experiments between IAPP, insulin, and proIAPP. Moreover, 
the outcome of this set of experiments will also shed some light on the possibility of 
intracellular fibrillation of proIAPP and its involvement in the extracellular plaque 
formation, which has been found in over 90% of the pancreas of T2DM patients (5).  
Thus, in order to understand proIAPP involvement in T2DM, we explored the 
modulation of proIAPP fibrillation by IAPP and insulin seeds and vice versa, by employing 
fluorescence and ATR-FTIR spectroscopy as well as AFM. 
 
3.4.1. Thioflavin T binding assay 
The thioflavin T (ThT) dye was used to track the aggregation kinetics of peptides and 
proteins in the presence and absence of seeds from different amyloidogenic peptides. As 
described in the materials and methods section, the ThT emission intensity at 482 nm 
increases upon binding to amyloid fibrils. Since the steps of fibril formation and ThT 
binding are simultaneous processes, an increase in ThT emission intensity at 482 nm was 
observed as the fibrillation kinetics of different amyloidogenic peptides under their 
respective conditions. ProIAPP seeds for the cross-seeding reaction were taken from the 
stationary phase of proIAPP fibrillation in the presence of 0.1 mM SDS (Figure 26), where 
proIAPP was shown to form only oligomeric structures as observed by AFM. 
As has been shown in Figure 45, IAPP fibrillation follows a sigmoidal curve with a 
lag phase of ~ 7 h, followed by an exponential growth phase for ~ 8 h. The addition of 4% 
proIAPP seeds to the IAPP fibrillation reaction mixture enhances the fibrillation rate, 
significantly. The lag phase reduces to ~ 1.5 h, and the exponential growth phase to 1 h. 
Hence, the presence of 4% proIAPP seeds in the IAPP fibrillation reaction enhances the 
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amyloidogenic propensity by fourfold. Moreover, the final ThT intensity of IAPP solution 
was also enhanced in the presence of proIAPP seeds (Figure 45). 
 
 
 
Figure 45: Thiflavin T monitored amyloid fibril formation of 20 µM IAPP in the absence (open black 
crosses) and presence (open red circles) of 4% (v/v) proIAPP seeds. The experiments were carried out in 10 
mM phosphate buffer, pH 7.4, at 25 °C. 
 
Insulin, which normally does not aggregate under physiological conditions at room 
temperature, was shown to form amyloid fibrils at a concentration of 0.5% (w/w), pH 2, at 
60 °C (28). This protocol was used to observe the effect of proIAPP seeds on the fibrillation 
kinetics of insulin (Figure 46). 
Insulin, like IAPP, follows a sigmoidal fibrillation kinetics with a lag phase of ~ 18 h 
followed by an exponential growth phase of ~ 14 h. The presence of 4% proIAPP seeds is 
only able to enhance the nucleation rate, but not the elongation rate of insulin fibrillation. 
Here, insulin follows fibrillation kinetics with a lag phase of ~ 10 h and an exponential 
growth phase of ~ 14 h (Figure 46). Moreover, the final ThT intensity is higher in the 
presence of proIAPP seeds, as also observed for the IAPP fibrillation upon addition of 
proIAPP seeds. 
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Figure 46: Thiflavin T monitored amyloid fibril formation of 667 µM insulin in the absence (open red 
triangles) and presence (open red circles) of 4% (v/v) proIAPP seeds. The experiments were carried out in 
H2O-HCl buffer, pH 2, at 60 °C. 
 
Thus, proIAPP seeds were able to enhance the amyloidogenic propensity of insulin 
and IAPP in their respective studied conditions. Thioflavin T binding assays were also done 
to underline the amyloidogenic propensity of proIAPP in the presence of IAPP and insulin 
fibrils. The 20 µM ProIAPP did not show any amyloidogenic propensity in the presence of 
respective 4% (v/v) seeds, as measured for 7 days in 10 mM phosphate buffer, pH 7.4, at 25 
°C. 
 
3.4.2. ATR-FTIR spectroscopy study 
Attenuated total reflection Fourier transform infrared spectroscopy was used to 
determine the arrangement of amide bond in amyloid fibrils grown in the presence and 
absence of seeds. IAPP in the presence of proIAPP seeds shows a prominent band at ~ 1623 
cm-1 along with a shoulder around 1646 cm-1 (Figure 47). However, IAPP fibrils, which 
were grown in the absence of proIAPP seeds, did not adsorb onto the silicon crystal at the 
beginning, therefore no signal was observed at time 0 h. Upon drying, significant 
absorbance of the amide-I’ band region corresponding to 1658 cm-1 and a shoulder at 1628 
cm-1 was observed (Figure 48). The wavenumber 1658 cm-1 corresponds to a mixture of α-
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helical and turn conformations of IAPP that was attained upon adsorption to the silicon 
ATR crystal, and the 1628 cm-1 band corresponds to the intermolecular β-sheets of an 
aggregated fraction of IAPP that settles onto the silicon crystal during the drying process. 
 
 
Figure 47: Amide-I’ vibration characteristics of IAPP fibrils, fibrillated in the presence of 4% proIAPP seed 
in 10 mM phosphate buffer, pH 7.4, at 25 °C. 
 
 
 
Figure 48: Amide-I’ vibration characteristics of IAPP fibrils, fibrillated in the absence of proIAPP seeds in 10 
mM phosphate buffer, pH 7.4, at 25 °C. 
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The amide-I’ band spectra (after 3 min) of insulin fibrils grown in the presence of 
proIAPP seed, show a prominent peak around 1637 cm-1 and a shoulder at ~ 1651 cm-1, 
indicating that the insulin fibrils have predominantly α-helices and intramolecular β-sheets 
content (Figure 49). The peak and shoulder corresponding to 1637 and 1651 cm-1 
wavenumbers shifts to 1627 and 1657 cm-1 wavenumbers upon drying on the silicon 
crystal. This peak shift is also accompanied by increase in absorbance at 1627 cm-1 peak. 
 
 
 
Figure 49: Amide-I’ vibration characteristics of insulin fibrils, fibrillated in the presence of 4% proIAPP 
seeds in H2O-HCl buffer, pH 2, at 60 °C. 
 
Insulin fibrils grown in the absence of proIAPP seeds show an amide-I’ band with a 
prominent peak corresponding to intermolecular β-sheets around 1627 cm-1 and a shoulder 
at 1661 cm-1 that upon drying show increase in absorbance, only. This shows that not all of 
the 667 µM insulin did fibrillate in the bulk, as revealed by the increase in the absorbance at 
1627 cm-1 during drying on the silicon crystal (Figure 50). 
Thus, at beginning the shape of amide-I’ band of insulin fibrils grown in the presence 
of proIAPP seeds, appeared to be rather similar to IAPP fibrils grown in the presence of 
proIAPP seeds (Figures 47 & 49), but with drying on crystal, the amide-I’ band shape 
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changed to the one shown by insulin fibrils grown in the absence of proIAPP seeds (Figure 
50)  
 
 
Figure 50: Amide-I’ vibration characteristic of insulin fibrils, fibrillated in the absence of proIAPP seed in 
H2O-HCl buffer, pH 2, at 60 °C. 
 
3.4.3. AFM study 
The morphologies of the fibrils grown in the presence and absence of seeds from the 
different amyloidogenic proteins or peptides were checked by AFM. ProIAPP did not show 
any fibrillar morphology in the presence or absence of IAPP and insulin fibrils under the 
conditions studied. However, proIAPP seeds had very different and varied effects on the 
fibrillar morphology of IAPP and insulin fibrils. As shown in Figure 51, insulin forms 
mainly amorphous, oligomeric or short fibrils in the absence of proIAPP seeds, in the 
studied condition as mentioned in the figure legend. The height of fibrils was found to be in 
the range of 5 - 6 nm. 
The presence of proIAPP seeds in the insulin fibrillation reaction mixture enhanced 
the fibrillation of insulin as observed by the ThT binding assay and the same was observed 
by AFM as well. Insulin was found to attain discrete fragmented and long fibrillar 
morphologies in the presence of proIAPP seeds. These fibrils were found to have a height 
of 3 - 4 nm (Figure 52). 
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Figure 51: AFM images of insulin aggregated at a concentration of 667 µM in H2O-HCl buffer, pH 2, 60 °C, 
at two different places (4x4 µm resolution). 
 
 
 
Figure 52: AFM images of insulin, aggregated at a concentration of 667 µM in H2O-HCl buffer, pH 2, 60 °C 
containing 4% proIAPP seeds, at 4x4 µm (left), 2x2 µm resolution (right). 
 
On the other hand, the fibrillar morphology of IAPP was drastically affected by the 
presence of proIAPP seeds. IAPP, in the absence of proIAPP seeds, was found to form long 
mature fibrils with a height of 4 - 5 nm (shown in Figure 53). IAPP forms amorphous 
aggregates along with the fibrils at the conditions studied here, as observed by the AFM 
images. 
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Figure 53: AFM images of IAPP, aggregated at a concentration of 20 µM in 10 mM phosphate buffer, pH 
7.4, 25 °C, at 4x4 µm resolution (left), 2x2 µm resolution (right). 
 
The proIAPP seeds added to the IAPP fibrillation reaction trapped the fibril formation 
in oligomeric species, only. IAPP is found to form predominantly oligomers in the presence 
of proIAPP seeds, with a height of 3 - 4 nm (Figure 54). The amorphous morphologies 
were absent in the AFM scan of the samples prepared from IAPP fibrillation reaction in the 
presence of proIAPP seeds (Figure 54), unlike the unseeded IAPP fibrillation (Figure 53). 
 
 
 
Figure 54: AFM images of IAPP, aggregated at a concentration of 20 µM in 10 mM phosphate buffer, pH 
7.4, 25 °C containing 4% (v/v) proIAPP seeds, at 4x4 µm resolution. 
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3.4.4. Discussion 
The proIAPP fibrils grown in the presence of 0.1 mM SDS formed mainly oligomers, 
as revealed by both AFM and ThT measurements. These structures were used as seeds for 
the fibrillation of IAPP and insulin, and vice versa. These studies were executed in order to 
reveal the potential role of proIAPP in enhancing the amyloidogenic propensity of IAPP 
and insulin, respectively, all three peptides being produced by islet β-cells, an aspect that 
might be relevant for the onset of T2DM. Different combinations of seeds and fibrils of 
these three peptides/proteins were tested for such effects. It was revealed that pre-formed 
seeds of IAPP and insulin had no effect on the amyloidogenic propensity of proIAPP, 
which shows no amyloidogenic characteristics in the absence of either seeds. This finding 
indicates that seeds of IAPP and insulin are not compatible as templates for proIAPP 
fibrillation. However, the seeds of proIAPP fibrils were able to enhance the amyloidogenic 
propensity of IAPP and insulin under their respective amyloid forming conditions, acting as 
templates for fibrillation. The lag phase was reduced in the fibrillation reaction of both 
peptides. IAPP shows drastic changes in its amyloid morphology in the presence of 
proIAPP fibrils. This may be explained through the amino acid sequence that proIAPP 
shares with IAPP; proIAPP is the precursor of IAPP. Thus, the proIAPP seeds provide a 
platform for an earlier onset of exponential growth, compared to IAPP fibrillation in the 
absence of proIAPP seeds. IAPP aggregates formed in the absence of proIAPP seeds 
exhibit both amorphous and fibrillar morphologies, as revealed by the AFM analysis. In a 
concomitant ATR-FTIR experiment, IAPP did not show any initial amide-I’ band, which 
suggests that IAPP was already aggregated in the bulk solvent and no significant adsorption 
at the silicon crystal was observed. However, upon drying with time, the amide-I’ band 
began to appear. The broad peak around 1658 cm-1 and the shoulder at 1628 cm-1 reveals 
that this structure contains more amorphous aggregates than ordered aggregates (Figure 
48), as confirmed by the AFM scans of the sample (Figure 53). This can be attributed to the 
higher concentration of IAPP used in the study. Otherwise, IAPP forms normally fibrillar 
structures, only. ProIAPP seeds can be used by IAPP molecules as templates for 
fibrillation, hence the major population of IAPP underwent an ordered (fibrillar) 
aggregation instead of an amorphous one, as shown by the ATR-FTIR spectra (Figure 47) 
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and AFM images (Figure 54). This modulation of IAPP fibrillation was also observed in the 
ThT kinetics assay (Figure 45). 
The amyloidogenic propensity of insulin was also enhanced in the presence of 
proIAPP, but not as drastic as observed for IAPP. This could be rationalized by the 
sequence similarity of proIAPP, IAPP and insulin. Since proIAPP shares its primary 
sequence with IAPP (hence some congruent side chain stacking and hydrogen bonding 
between the backbone of the two peptides is possible), the compatibility of proIAPP seeds 
was sufficient in fostering the fibrillation process of IAPP. Insulin lacks this homology with 
the proIAPP sequence. Hence, proIAPP seeds were not as efficient in accelerating the 
insulin fibrillation process as observed for IAPP. Thus, at the beginning, the position and 
shape of the amide-I’ band measured for insulin (ATR-FTIR) appeared to be rather similar 
to that observed when IAPP fibrils grew in the presence of proIAPP seeds (Figures 47 & 
49), but upon drying on the crystal with time, the amide-I’ band adopted a similar shape as 
observed for insulin fibrils formed in the absence of proIAPP (Figure 50). 
Hence, proIAPP seeds are very efficient in enhancing the amyloidogenic propensity 
of IAPP and insulin, while IAPP and insulin seeds are not able to do the same for proIAPP. 
To verify these conclusions, further experiments are still needed to be performed with 
varying the percentage of insulin, IAPP and glucagon (a hormone secreted by α-cells of 
pancreas) seeds, in order to further explore the possibility of proIAPP involvement in 
amyloid plaque formation. This information will be of substantial importance for the 
understanding of the onset and progression of T2DM. 
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Chapter 4. Summary 
The aim of this PhD thesis was to understand and to explore the effects of negatively 
charged surfactants and membrane surfaces on the amyloidogenic propensity of proIAPP. 
In addition, the effects of seeds from different amyloidogenic peptides/proteins secreted by 
pancreatic β-cells on proIAPP fibrillation and vice versa were explored in vitro. This work 
should thus help in understanding the role of negatively charged cellular moieties and 
surfaces in the onset and progression of T2DM. Since the knowledge of the influence of 
lipid membranes on the amyloidogenic propensity of proIAPP has been quite rare, the first 
approach adopted was to investigate the putative effects of lipid membranes by taking a 
simple negatively charged membrane-mimicking model, SDS. Thereafter, this approach 
was extended to lipid monolayers in order to understand the insertion/adsorption of 
proIAPP at different surface pressures at a D2O-lipid monolayer interface by IRRAS. This 
approach would help to understand the dynamics and conformation of the peptide bonds of 
proIAPP during the interaction with lipid monolayers resulting in amyloid fibril formation 
below and near the intracellular membrane’s lateral pressure. The following part of the 
thesis dealt with the effects of lipid bilayer membranes possessing diverse 
anionic/zwitterionic lipid compositions on the amyloid fibril formation of proIAPP and 
proIAPP-IAPP mixtures. This helps in understanding the underlying mechanism of the role 
of lipid interfaces in proIAPP fibril formation, and subsequently the function of proIAPP 
and abnormally higher anionic cellular membrane contents in the onset and progression of 
T2DM. Finally, cross-seeding experiments with seeds from different amyloidogenic 
proteins/peptides, secreted by pancreatic β-cells, i.e. proIAPP, IAPP and insulin, were 
carried out in order to determine the compatibility of seeds from one amyloidogenic peptide 
with the others, thus helping identify the potent primary culprit of T2DM. 
The role of a negatively charged membrane-mimicking agent as well as negatively 
charged cellular moieties on the early intracellular amyloid formation of proIAPP was 
studied using SDS. The SDS concentration had differential effects on the amyloidogenic 
propensity of proIAPP. SDS retains a monomeric structure below the CMC, whereas a 
gradual appearance of micelles starts near the CMC. ProIAPP, which did not show any 
amyloidogenic propensity in bulk solution, underwent fibril formation in a concentration 
range of 0.1 to 1.0 mM SDS, only. The monomeric structure of SDS interacts with proIAPP 
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and induces regular secondary structures in proIAPP. These partially folded proIAPP 
molecules fibrillate with relatively fast fibrillation rates. For SDS concentrations above the 
CMC, proIAPP molecules ceased to undergo fibril formation due to folding into stable α-
helical conformations. The gain in the amyloidogenic propensity of proIAPP (for SDS 
concentrations < CMC) is probably rationalized by the screening of electrostatic repulsion 
between proIAPP molecules, in addition to the folding of proIAPP molecules into a 
partially folded amyloidogenic conformation, while the loss of the amyloidogenic 
propensity of proIAPP (for SDS concentrations > CMC) can be attributed to the binding of 
peptides to micelles that is expected to sterically hinder the close proximity needed for the 
self-assembly otherwise leading to fibril formation. Thus, it can be concluded that the 
aberrant folding of proIAPP into a partially folded conformation can lead to early 
intracellular amyloid fibril formation via interaction with negatively charged cellular 
moieties. Additionally, the folding of proIAPP into a stable conformation (α-helices) 
prohibits its involvement in early intracellular amyloid fibril formation, as suggested by the 
results in the presence of SDS at a concentration above the CMC value. 
The SDS approach was followed by lipid monolayer studies in order to investigate the 
insertion/adsorption of proIAPP at different surface pressures at a D2O-lipid interface by 
IRRAS and AFM. ProIAPP adsorption at the negatively charged lipid monolayer (POPG)-
D2O interface started immediately after the addition of lipid onto the subphase, as 
concluded from the increase in surface pressure. The adsorption of proIAPP onto the 
POPG-D2O interface showed the induction of an α-helical structure in the proIAPP 
molecules. This adsorbed proIAPP underwent amyloid fibril formation as verified by AFM. 
However, no transition in the infrared wavenumbers from α-helix to β-sheet could be 
detected in the IRRA spectra. This could be explained by the diffusion of proIAPP 
molecules from the sample trough to the reference trough with an increase of the surface 
pressure > 24 mN/m, except for the mutant variant, which remained α-helical within the 
studied time frame. Thus, the conformational transitions found for proIAPP in the sample 
trough was subtracted from the conformational transitions in proIAPP which diffused into 
the reference trough. As a result, the amyloid fibril morphologies were found in both 
troughs by AFM analysis. Nevertheless, this approach helped in understanding the 
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conformational dynamics of proIAPP during amyloid fibril formation upon interaction with 
lipid monolayer membranes. 
After observing the behaviour of proIAPP at negatively charged lipid monolayers at 
different lateral pressures, model bilayer membranes were studied. This part of the thesis 
was meant to understand the conformational transition during proIAPP fibrillation at 
various model membrane surfaces. In addition, to understand the conformational dynamics 
during proIAPP fibrillation, our goal was to reveal the putative mechanism of proIAPP 
aggregation in the presence of various model membrane systems, including heterogeneous 
model raft mixtures. ProIAPP adsorbs with a slow rate at the anionic membrane system 
used (DOPC:DOPG 7:3, w:w). This adsorption was subsequently followed by a gradual 
conformational transition from an unordered structure to intermolecular β-sheets. Thus, this 
observation is rationalized by factors like an increasing proIAPP concentration upon 
adsorption at the membrane surface and formation of a partially folded conformation, 
which helped to approximate proIAPP molecules for self-assembling into amyloid fibrils. 
This phenomenon was absent at lower concentrations of proIAPP. Additionally, this 
process did also not occur in the presence of a pure zwitterionic membrane (DOPC), a 
membrane with a lower anionic lipid content (< 30% DOPG) and a model raft mixture 
(DOPC:DPPC:Chol, 1:2:1). Unlike other amyloidogenic peptides/proteins, proIAPP 
(DOPC:DOPG, 7:3) forms oligomeric or short fibrillar structures only at anionic 
membranes. Additionally, the presence of proIAPP monomers in IAPP fibrillation reduced 
the fibrillation kinetics of IAPP at anionic membranes (DOPC:DOPG, 7:3). Hence, it seems 
likely that in the prediabetic stage, a remodulation of the cellular membrane’s composition 
can be a leading/stimulating factor in the onset of intracellular nucleus formation, followed 
by the progression of extracellular deposits of amyloid plaques in T2DM patients. 
Finally, the compatibility of seeds from different amyloidogenic peptides/proteins 
secreted by pancreatic β-cells, i.e., insulin, proIAPP, and IAPP, in the fibrillation reaction 
of other monomeric peptides/proteins secreted by the same cells was analyzed, since 
proIAPP and proinsulin are processed by the same processing enzymes, stored in the same 
secretory granules and secreted in response to the same stimuli. Fluorescence and ATR-
FTIR spectroscopy, as well as AFM, showed that IAPP and insulin seeds were unable to 
induce amyloid structures in proIAPP. However, seeds from proIAPP were able to enhance 
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the amyloidogenic propensity of IAPP and insulin, by reducing the nucleation (lag) phase. 
The presence or absence of proIAPP seeds did not have a significant effect on the amide-I’ 
band of the fibrils obtained from IAPP and insulin. However, the morphology of the IAPP 
fibrils was drastically affected by the addition of proIAPP seeds to the fibrillation reaction. 
IAPP formed only oligomers in the presence of seeds from proIAPP, instead of the mature 
fibrils that are found in the absence of proIAPP seeds. ProIAPP has a minor effect on the 
fibrillar morphology of insulin, compared to the unseeded fibrillation, and exhibits 
predominantly fragmented fibrils along with some longer fibrils. The formation of the IAPP 
oligomers may be attributed to the incorporation of proIAPP molecules with the growing 
IAPP aggregates during the aggregation reaction, and the extended positively charged N- 
and C- termini of the incorporated proIAPP probably sterically hinder the elongation of 
oligomers into mature fibrils. Thus, the seeds from proIAPP are able to enhance the 
amyloidogenic propensity of IAPP and insulin, but not vice versa. 
To conclude, a simple hypothesis may be postulated: 
“An increase in the cellular composition of anionic moieties or interfaces in the 
prediabetic stage of T2DM may lead to the formation of intracellular proIAPP oligomers or 
short fibrils, which upon exposure to IAPP and insulin monomers may progress to 
pathological amyloid plaque formation in T2DM”. 
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Chapter 5. Zusammenfassung 
Ziel der vorliegenden Dissertation war die Untersuchung des Einflusses negativ 
geladener, grenzflächenaktiver Substanzen und Oberflächen auf die amyloidogenen 
Eigenschaften von proIAPP. Des Weiteren wurde der Effekt von Fibrillenkeimen (engl. 
seeds) unterschiedlicher amyloidogener Peptide/Proteine, die von pankreatischen β-Zellen 
sekretiert werden, auf die Fibrillierung von proIAPP in vitro analysiert. Diese Ergebnisse 
tragen zu einem besseren Verständnis der Funktion von negativ geladenen zellulären 
Komponenten und Oberflächen während des Ausbruchs und Verlaufs von T2DM bei. Da 
der Einfluss von Lipidmembranen auf die amyloidogenen Eigenschaften von proIAPP noch 
weitgehend unbekannt ist, wurden zunächst mögliche Effekte durch die Verwendung von 
SDS untersucht, welches ein einfaches, negativ geladenes, membrannachahmendes 
Modellsystem darstellt. Im Folgenden wurde dieser Ansatz auf Lipidmonoschichten 
ausgeweitet, um mit Hilfe der IRRA-Spektroskopie einen Einblick in die Einlagerung bzw. 
Adsoption von proIAPP bei unterschiedlichen Oberflächendrücken in bzw. an der D2O – 
Lipidmonoschicht-Grenzfläche zu erhalten. Diese Methodik erlaubt eine genauere Kenntnis 
der Peptidbindungsdynamik des proIAPPs während der Wechselwirkung mit 
Lipidmonoschichten unterhalb und nahe dem in intrazellulären Membranen 
vorherrschenden lateralen Druck, wobei die Interaktion zur Amyloidfibrillenbildung führt. 
Ein weiterer Teil dieser Dissertation beschäftigte sich mit dem Einfluss von 
Lipiddoppelschichtmembranen mit unterschiedlichen Anteilen an anionischen und 
zwitterionischen Lipiden auf die Amyloidfibrillenbildung von proIAPP sowie Mischungen 
von proIAPP mit IAPP. Diese Ergebnisse helfen, den Mechanismus der proIAPP-
Fibrillierung in Anwesenheit von Membranen und die Anwesenheit von hohen anionischen 
Lipidanteilen zellulärer Membranen während der Ausbildung und des Verlaufes von T2DM 
besser zu verstehen. Abschließend wurden Kreuzwechselwirkungsexperimente mit 
Fibrillenkeimen von unterschiedlichen amyloidogenen Peptiden/Proteinen, die von 
pankreatischen β-Zellen sekretiert werden (wie z.B. proIAPP, IAPP und Insulin), 
durchgeführt, um die Kompatibilität von Fibrillenkeimen eines amyloidogenen Peptides zu 
einem anderen zu untersuchen. Dies soll die primär wirksame Spezies von T2DM 
identifizieren helfen. 
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Die Experimente mit der negativ geladenen, membrannachahmenden Substanz SDS 
zeigen in Abhängigkeit der SDS-Konzentration unterschiedliche Effekte auf die Neigung 
des proIAPPs zur Amyloidbildung, da SDS unterhalb der kritischen Mizellkonzentration 
(CMC) seine monomere Struktur beibehält, während nahe der CMC eine sukzessive 
Ausbildung von Mizellstrukturen erfolgt. In Bulk-Lösung wies proIAPP kein 
amyloidogenes Verhalten auf, es bildete jedoch bei SDS-Konzentration zwischen 0,1 und 
1 mM Fibrillen aus. Dabei wechselwirkt die monomere Konformation von SDS mit 
proIAPP und induziert reguläre Sekundärstrukturen. Diese partiell gefalteten proIAPP-
Moleküle fibrillieren mit vergleichsweise schnelleren Fibrillierungsgeschwindigkeiten. 
Liegt die SDS-Konzentration oberhalb der CMC, bildet proIAPP stabile α-helikale 
Konformationen aus und umgeht so die Fibrillenbildung. Die verstärkte Neigung von 
proIAPP zur Amyloidbildung bei SDS-Konzentrationen unterhalb der CMC basiert 
wahrscheinlich auf der Abschirmung der elektrostatischen Abstoßungskräfte zwischen den 
proIAPP-Molekülen, zusätzlich zur Faltung der pro-IAPP-Moleküle in teilweise gefaltete 
amyloidogene Strukturen. Im Gegensatz dazu lässt sich die Herabsetzung der amyloid-
bildenden Eigenschaften des pro-IAPPs bei SDS-Konzentrationen oberhalb der CMC auf 
die Bindung des Peptids an die Mizellen zurückführen, wobei von einer sterischen 
Hinderung der für die Selbstassoziation benötigten unmittelbaren Nähe ausgegangen wird, 
die ansonsten zu einer fibrillären Morphologie führen würde. Demzufolge kann zweifelsfrei 
angenommen werden, dass die anomale Faltung des proIAPPs in eine partiell gefaltete 
Konformation zu einer frühen intrazellulären Amyloidfibrillenbildung aufgrund von 
Wechselwirkungen mit negativ geladenen zellulären Komponenten führt. Weiterhin 
verhindert die Faltung des proIAPPs in eine stabile (α-helikale) Konformation die 
Ausbildung früher intrazellulärer Amyloidfibrillen, wie die Ergebnisse in Anwesenheit von 
SDS bei Konzentrationen oberhalb der CMC nahe legen. 
Die folgenden Studien mit Lipidmonoschichten erlauben Aussagen über die 
Einlagerung bzw. Adsorption von proIAPP an der D2O-Lipidgrenzfläche bei verschiedenen 
Oberflächendrücken. Dabei konnte mittels IRRAS gezeigt werden, dass die Adsorption von 
proIAPP an der negativ geladenen Lipidmonoschicht (POPG)-D2O-Grenzfläche sofort nach 
Spreitung des Lipids auf der Subphase erfolgt, was durch einen Anstieg des 
Oberflächendrucks nachgewiesen wurde. Die Adsorption führt zur Ausbildung α-helikaler 
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Strukturen der proIAPP-Moleküle. Diese adsorbierte Form unterliegt der Fibrillenbildung, 
welche mittels AFM nachgewiesen wurde, obwohl in den IRRA-Spektren keine 
Verschiebung der Wellenzahl von α-Helix zu β-Faltblatt beobachtet werden konnte. 
Letzteres lässt sich durch die Diffusion von proIAPP vom Probentrog in den Referenztrog 
mit steigendem Oberflächendruck (> 24 mN/m) begründen. Allerdings behielt die mutierte 
Spezies über den beobachteten Zeitraum ihre α-helikale Struktur bei. Folglich wurde die im 
Probentrog beobachtete Konformationsänderung des proIAPPs um die im Referenztrog 
ermittelte korrigiert. Daraus ergab sich der Nachweis einer amyloidogenen 
Fibrillenmorphologie in beiden Trögen mit Hilfe der Rasterkraftmikroskopie. Trotzdem 
konnte mit Hilfe dieses Ansatzes die Konformationsdynamik des proIAPPs während der 
durch Lipidmonoschichten induzierten Amyloidfibrillenbildung besser verstanden werden. 
Nachdem die Eigenschaften von proIAPP in Gegenwart von negativ geladenen 
Lipidmonoschichten bei unterschiedlichen Oberflächendrücken analysiert wurden, erfolgte 
nun die Betrachtung von Modellsystemen, die sich aus Lipiddoppelschichten 
zusammensetzen. Dieser Teil der Dissertation diente dazu, den Strukturwechsel des 
proIAPPs während der Fibrillierung an verschiedenen Modellmembranoberflächen näher 
zu untersuchen. Des Weiteren sollte ein möglicher Mechanismus der Aggregation von 
proIAPP in Gegenwart verschiedener Modellmembransysteme aufgezeigt werden, 
inklusive heterogener Modellraftmembranen. Dabei zeigte sich, dass proIAPP an 
anionischen Membransystemen (DOPC:DOPG 7:3, w/w) langsam adsorbiert, wobei sich 
der Adsorption eine schrittweise Konformationsänderung von ungeordneten zu 
intermolekularen β-Faltblattstrukturen anschließt. Diese Beobachtungen lassen sich mit 
einem Anstieg der proIAPP-Konzentration an der Membranoberfläche während der 
Adsorption sowie der Ausbildung von partiell gefalteten Strukturen erklären, wobei die 
daraus resultierende große Nähe der proIAPP-Moleküle zueinander eine Selbstassoziation 
zu Amyloidfibrillen erleichtert. Dieses Phänomen konnte nicht bei geringeren proIAPP-
Konzentrationen nachgewiesen werden und war auch in Anwesenheit einer reinen 
zwitterionischen Membran (DOPC) sowie einer Membran mit geringem anionischen 
Lipidanteil (< 30% DOPG) und einer Modellraftmembran (DOPC:DPPC:Chol, 1:2:1) nicht 
detektierbar. Im Gegensatz zu anderen amyloidogenen Peptiden/Proteinen bildete proIAPP 
an anionischen Membranen (DOPC:DOPG, 7:3) lediglich oligomere und kurze fibrilläre 
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Strukturen aus. Des Weiteren führte die Anwesenheit von proIAPP-Monomeren während 
der Fibrillenbildung von IAPP an anionischen Membranen (DOPC:DOPG, 7:3) zu einer 
verlangsamten Fibrillierungskinetik des IAPPs. Folglich scheint im prädiabetischen 
Stadium die Anpassung der zellulären Membranzusammensetzung ein ausschlaggebender 
Faktor zu Beginn der intrazellulären Keimbildung zu sein, in deren weiterem Verlauf 
extrazelluläre Ablagerungen amyloidogener Plaques bei Patienten mit T2DM auftreten. 
Abschließend erfolgte in dieser Arbeit eine Analyse der gegenseitigen 
Austauschbarkeit von Fibrillenkeimen verschiedener amyloidogener Peptide/Proteine, wie 
z.B. proIAPP, Insulin und IAPP, während der Fibrillierung anderer monomerer 
Peptide/Proteine, die von den gleichen pankreatischen β-Zellen sekretiert werden, da 
proIAPP und Proinsulin von den gleichen Enzymen prozessiert und in den gleichen 
sekretorischen Granula gespeichert werden sowie der Auslöseimpuls zur Sekretion derselbe 
ist. Mit Hilfe der Fluoreszenz- und ATR-FTIR-Spektroskopie sowie der 
Rasterkraftmikroskopie konnte gezeigt werden, dass Fibrillenkeime von IAPP und Insulin 
keine Ausbildung amyloidogener Strukturen beim proIAPP induzieren können. Allerdings 
war umgekehrt eine Verstärkung der Neigung zur Amyloidbildung bei IAPP und Insulin 
durch proIAPP-Fibrillenkeime mittels einer verkürzten Keimbildungsphase nachweisbar. 
Die An- oder Abwesenheit von proIAPP-Fibrillenkeimen hatte dabei keinen signifikanten 
Einfluss auf die Amid-I′-Bande der IAPP- bzw. Insulinfibrillen. Indes wurde die 
Morphologie der IAPP-Fibrillen drastisch durch die Anwesenheit der proIAPP-
Fibrillenkeime während der Aggregation beeinflusst. Anstelle gereifter Fibrillen bildete 
IAPP in Anwesenheit von proIAPP-Fibrillenkeimen lediglich Oligomere. Dagegen wurde 
die Morphologie der Insulinaggregate im Vergleich zur Aggregation ohne Keimzugabe nur 
geringfügig durch die proIAPP-Fibrillenkeime beeinflusst. Insulin wies neben einigen 
längeren Fibrillen hauptsächlich fragmentierte Fibrillen auf. Die Morphologie der IAPP-
Oligomere lässt sich auf die Einlagerung von proIAPP-Molekülen in die IAPP-Aggregate 
während der Aggregation zurückführen. Aufgrund der ausgedehnten positiv geladenen N- 
und C-Termini des eingelagerten proIAPPs tritt eine sterische Hinderung beim Anwachsen 
der Oligomere zu gereiften Fibrillen auf. Folglich sind Fibrillenkeime vom proIAPP stärker 
kompatibel und steigern die Amyloidogenität von IAPP und Insulin, während der 
umgekehrte Vorgang nicht zu beobachten ist. 
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Auf Grundlage der Ergebnisse der vorliegenden Dissertation lässt sich 
zusammenfassend folgende Hypothese aufstellen: 
"Eine Erhöhung der zellulären Zusammensetzung mit anionischen Komponenten und 
Oberflächen im prädiabetischen Stadium der T2DM scheint zur Ausbildung von 
intrazellulären proIAPP-Oligomeren oder kurzen Fibrillen zu führen, was im weiteren 
Verlauf durch die Wechselwirkung mit IAPP- und Insulinmonomeren zu einer Ablagerung 
pathologischer Amyloidplaques führen kann". 
 99 
 
Chapter 6. Appendix 
 
 
 
 
Figure A: Upper panel: BL21(DE3) E. coli cells expression for induced proIAPP production, from right: 
lanes 1 & 2 - cytosol; lanes 3 & 4 - eluate as cytosol passed through Ni-NTA beads; lanes 5 & 6 - on Ni 
beads; lane 8 - marker. Lower panel: After cleavage of fusion protein with enterokinase enzyme, lane 3 and 4 
shows proIAPP; lanes 2 & 5 shows the rest of the cleaved part of fusion protein. 
 
 100 
 
 
 
Figure B: Electron spray ionization mass spectroscopy data to identify the purity and mass of the purified 
peptide (fusion proIAPP). The graph shows the mass by charge ratio (m/z) vs. the relative abundance of the 
species; the inset shows the mass of the species present in the sample. 
 
 
 
 
Figure C: Electron spray ionization mass spectroscopy data to identify the purity and mass of the purified 
peptide (proIAPP). The graph shows the mass by charge ratio (m/z) vs. the relative abundance of the species; 
the inset shows the mass of the species present in the sample. 
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Figure D: 20 µM proIAPP aggregation on a silicon crystal in the presence of 0.1 mM SDS in 10 mM 
phosphate buffer, pD 7.4, at room temperature. The time evolution of the amide-I’ band shows the appearance 
of antiparallel β-sheets and helical conformations during the process of aggregation on the silicon crystal. 
 
 
 
 
Figure E: AFM image of proIAPP oligomers grown in the presence of 0.1 mM SDS that were used as seeds 
for enhancing the fibrillation kinetics of IAPP and insulin at their respective amyloidogenic conditions. 
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